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ABSTRACT 
Making nanocomposites from combinations of materials each with their own unique 
functional advantage can often solve issues that cannot be addressed when utilizing only one 
type of materials. Therefore, controlling nanosturucture and nanoarchitecture have become 
central issues in both high performance energy devices and nanobiomedical applications. 
Biological systems can provide precise control over materials interaction between peptides 
and other non-biological materials through biological molecular recognition, and the 
capability of modifying and controlling materials interaction through genetic engineering 
provides an attractive route to creating new nano-structured hybrid materials systems.  
 
In this thesis work, new approaches to effectively incorporate single-walled carbon nanotubes 
(SWNTs) into energy devices are presented. Genetically engineered M13 virus clones are 
developed to assemble SWNTs and technically important inorganic materials biomineralized 
on the protein surfaces of M13 virus to create hybrid nano-structured electrodes for high-
power Li-ion batteries and highly efficient photovoltaic devices. Moreover, new imaging 
probes for molecularly targeted fluorescence imaging of tumors are developed by utilizing the 
highly bright and water-stable SWNTs and genetically modifiable M13 virus. The 
fundamental understanding and new approaches this work presents will provide new insight 
into designing materials for high performance energy devices and nanobiomedical 
applications. 
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1.1. Motivation 
 
Clearly, one of the main issues for the 21st century is energy and environment. People 
have been trying to develop new ways to harvest solar energy more efficiently (1, 2), convert 
solar energy to produce fuels such as hydrogen which can be stored and used for fuel cells (3, 
4), and fabricate rechargeable high power batteries using environmentally benign technologies 
(5, 6). Considering the extreme diversity of the different types of devices, materials systems, 
and fabrication methods, it seems impossible to have a universal strategy applicable to all 
energy applications. However, if we are reminded of the fact that electrochemically driven 
energy or photo-excited and generated energy is all transferred by either electrons or ions and 
sometimes electron transport is a rate limiting step, we could derive a general strategy: 
enhanced transport of electrons throughout the electrochemically active or photo-catalytic 
materials could improve performance metrics of energy devices such as rate capability (7) or 
light harvesting efficiency (8). In this context, for some energy devices it is a key issue to 
create precisely controlled-nanomaterials complexes that provide both well-percolating and 
efficient electron pathways and serve as energy conversion components.   
Biological systems can provide precise control over materials interaction between 
peptides and other non-biological materials through biological molecular recognition. 
Identification of materials specific peptides through combinatorial methods combined with 
biomineralization has broadened the range of biological approaches to nanotechnology and 
nanoelectronics. In our lab, a filamentous (~ 6.5 nm in diameter and ~ 880 nm in length) M13 
bacteriophage (phage or virus)-based biological toolkit has been developed for materials 
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synthesis and assembly in a multiple length-scale (6, 9, 10). Various capsid proteins of M13 
virus located at different positions can be genetically engineered for controlled materials 
interaction to serve as a template for various materials synthesis and/or as a scaffold binding 
various materials of interest. The capability of modifying and controlling materials interaction 
through genetic engineering and its filamentous shape and dimension make M13 virus an 
attractive toolkit toward creating new nano-structured hybrid materials system (11-13).  
The excellent electrical and optical properties of single-walled carbon nanotubes 
(SWNTs) as well as their high surface to volume ratio and chemical stability render them an 
ideal component for nano-structured hybrid electrodes (8). There have been many efforts to 
utilize SWNTs as a scaffold for anchoring photoactive nanomaterials or as a conduction path 
to direct the flow of charge carriers in solar cells (14-17) and betteries (ref). They have been 
also employed as a scaffold to disperse catalysts and improve the oxygen reduction efficiency 
in fuel cells (8, 18). In most cases, however, the active nanomaterials are dispersed 
nonspecifically on the surface of the pre-deposited SWNTs networks. These approaches to 
creating hybrid structure through non-specific adsorption cannot provide well-controlled 
hybrid structures throughout the whole system. On the other hand, covalent functionalization 
of the surface of SWNTs to get specific binding of active nanomaterials perturbs the 
electronic property of SWNTS, degrading overall performance of the device. By engineering 
multiple sites on the viral capsid, however, it is possible to control intimate contacts between 
active nanomaterials and SWNTs without disturbing the electronic properties of SWNTs (19, 
20).  
  18 
SWNTs also show great promise as in vivo imaging agents due to their unique optical 
properties (21-24). In particular, their photoluminescence (PL) in the second near-infrared 
(NIR) window (950-1,400 nm) and their interband transitions in the first NIR window (650 -
950 nm) allowing for excitation far from the emission line make SWNTs promising imaging 
agents for in vivo fluorescence imaging due to deeper penetration of light through tissue and 
low autofluorescence (25). If second NIR fluorescent SWNTs can be equipped with targeting 
functionality, then the capability of in vivo fluorescence imaging will be enhanced for 
accurate, specific detection of diseased areas. Although SWNTs have previously been used 
for live cell imaging in vitro (26) and in vivo whole animal imaging (23, 24), actively 
targeting in vivo fluorescent imaging has never been achieved. This is most likely because it is 
challenging to add targeting moieties to the small coating molecules that are commonly used 
to disperse hydrophobic SWNTs while keeping the fluorescence of SWNTs high enough for 
in vivo imaging. However, if we engineer various coat proteins of M13 virus for different 
functionality independently, it is possible to incorporate targeting capability into SWNTs 
without compromising the stability of SWNTs.  
In this thesis work, new approaches to effectively incorporate SWNTs into energy devices 
are presented. Genetically engineered M13 virus clones are developed to assemble SWNTs 
and technically important inorganic materials biomineralized on the protein surfaces of M13 
virus to create hybrid nano-structured electrodes for high power Li+ ion batteries and highly 
efficient photovoltaic devices. Moreover, new imaging probes for molecularly-targeted 
fluorescence imaging of tumors are developed by utilizing the highly bright and water-stable 
SWNTs and genetically modifiable M13 virus. 
  19 
1.2.The scope and structure of this thesis 
 
This thesis research focuses on fundamental understanding of interaction between 
biological materials and inorganic or non-biological materials, and developing new hybrid 
materials platforms based on the understanding of materials interaction and utilization of 
genetic engineering for high performance energy devices and nanobiomedical applications.  
In chapter 2, M13 virus is introduced as a versatile materials toolkit and various 
approaches necessary to fully utilize the versatility of M13 virus are described. Moreover, 
methods to manipulated SWNTs with M13 are developed. In chapter 3, an approach to 
fabricating hybrid electrode materials for high power Li ion batteries is described. In this 
work, multiple genes of M13 virus are engineered to make a hybrid electrode structures out of 
electrochemically active inorganic materials, amorphous FePO4, and conducting SWNTs. In 
chapter 4, biologically self-assembled core-shell SWNT-TiO2 hybrid photo-anodes are 
fabricated to increase electron collection efficiency in photovoltaic devices. In this work, 
SWNTs are dispersed by M13 virus through ‘pH switch’ method and improve device 
performance of dye-sensitized solar cells through enhanced electron collection efficiency. In 
chapter 5, M13 viruses are engineered to functionalize SWNTs for molecularly targeted 
imaging of tumors using second near-infrared fluorescence. By employing genetically 
modifiable, multifunctional M13 virus, SWNTs have been successfully utilized for targeted 
fluorescence in vivo imaging for the first time. In chapter 6, M13 virus/SWNTs complexes 
are utilized as a platform for effective theranostic agents. Targeted virus-SWNT complex 
demonstrates selective and sensitive fluorescence imaging of prostate cancer cells, and drugs 
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delivered by the targeted virus complex inhibited cell growth of targeted cancer cells at least 
245 times more efficiently than free drug. In chapter 7, on-going research works extended 
this thesis works are presented.  
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Chapter 2. Developing M13 virus/single-walled 
carbon nanotube complexes for a versatile 
materials platform 
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2.1. Introduction 
 
A single-walled carbon nanotube is a rolled-up graphene sheet, whose diameter is 
around 1 nm and length is several hundreds of nm. Graphene is an allotrope of carbon, and is 
one-atom-thick planar sheets of sp2-bonded carbon atoms that are densely packed in a 
honeycomb crystal lattice. The rolling vector is called a chiral vector and the size and the 
direction of the chiral vector determines the electrical and optical properties of SWNTs 
(Fig.2.1). For example, the bigger chiral vector, therefore the bigger diameter of SWNTs 
gives smaller bandgap energy of SWNTs. In addition, the difference in n and m, (n-m), 
determines whether SWNTs are metallic or semiconducting.  
In spite of the numerous advantages of single-walled carbon nanotubes (SWNTs) such 
as very high electron mobility, band-gap photoluminescence in the near-infrared window, and 
one-dimensional shape, the difficulty in dispersing them non-covalently due to strong van der 
Waals interaction, and the mixed ensemble of semiconducting and metallic SWNTs have 
prevented their widespread use. There have been many reports on successful dispersion of 
SWNTs with surfactants (1,2), DNA (3), peptides (4,5) and polymers (6) in aqueous solution. 
However, because surfactants do not have specific affinity toward SWNTs, they wrap 
impurities in the solution as well. Moreover, when the concentration of surfactants is below 
their critical micelle concentration, they do not disperse SWNTs and SWNTs start to 
aggregate and eventually to flocculate. Moreover, it is challenging to add multifunctionality to 
SWNTs when dispersed by small coating molecules such as DNA, peptides, and polymers 
without disrupting its electronic properties because the additional functionality often 
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compromises the stability of SWNTs. Therefore, it is required to develop a way to efficiently 
incorporate SWNTs into various structures/devices for desired performance.  
M13 bacteriophage (phage or virus) is a type of filamentous virus whose dimension is 
about 880 nm in length and 6-7 nm in width. M13 virus has five genetically modifiable 
proteins (proteins p3, p6, p7, p8, and p9) that can display material-specific peptides or 
targeting motifs on various coat proteins (7-9) (Fig.2.2a). By employing a phage-display 
peptide library combined with a bio-panning approach, various peptide sequences with 
binding affinity toward materials of interests can be identified and utilized for various 
applications (7, 10, 11). With the help of genetic engineering and the possibility of 
independent modification of multiple virus genes, M13 virus can serve as a platform for a 
hybrid materials system. Moreover, the very regular helical structure of p8 major coat 
proteins, wrapping the single-strained DNA of M13 virus with 5-fold rotational symmetry and 
2-fold screw symmetry (12), makes it possible to stabilize SWNTs with M13 virus of 
displaying p8 peptide inserts with strong binding affinity to SWNTs.  
In order to identity peptide sequences to show binding affinity toward materials of 
interest, a peptide library is required. A p3 phage-display peptide-library has been widely used 
for peptide identification because it is commercially available (New England Biolabs.) and the 
structure of p3 coat proteins are relatively flexible and open compared to p8 coat proteins, 
making it possible to fuse peptides with less limit to the size. However, the peptide sequence 
identified in a p3 library does not show the same binding affinity toward the same target of 
interest when fused onto the p8 protein because the secondary structures of p3 and p8 proteins 
are different. Moreover, p8 protein can bear only 5-6 additional amino acid inserts (13) 
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whereas the libraries commercially available have inserts of 10-15 amino acids. Therefore, in 
order to manipulate SWNTs with p8 coat proteins of M13 virus, extending the possibility of 
M13 virus as a materials platform, p8 phage-display library must be constructed.  
In this chapter, construction of p8 phage-display peptide-library is described and 
methods to make M13 virus/SWNT complexes are developed for making hybrid 
nanostructures, and stable, multifunctional SWNTs for biomedical applications, to be utilized 
in later chapters 4,5, and 6. Incorporating SWNTs into hybrid materials through p3 of M13 
virus is described in chapter 3.  
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2.2. Experimental 
 
2.2.1. Construction of p8 phage-display peptide-library 
An M13 phage-display peptide library is an ensemble of M13 virus clones, each of 
whose p8 coat proteins is inserted with random foreign peptide inserts at the amino (N)-
terminus. Each M13 virus clone has a different p8 sequence and all the p8 coat proteins are 
the same within the one M13 virus (Fig. 2.3). The peptide sequence is fused at the N terminus 
of p8 coat protein preceded by alanine (A) through genetic engineering. 
 
a) Randomized 8-mer p8 phage-display peptide-library 
M13SK, a vector derived from a commercially available M13KE vector (New 
England Biolabs.), was used for p8 library construction (14). In order to construct randomized 
p8 library, 8-mer peptide sequence, N-X’XXXXXXX’-C where X’ is partially randomized 
animo acid sequence due to the codon constraint at each terminal and X is fully randomized 
amino acid, is incorporated into p8 coat proteins of M13 virus. Library oligonucleotide 
(idtdna) was designed to fuse randomized 8-mer peptide sequence onto p8 with digestion 
enzyme recognition sites for BamH I and Pst I, 3’ AC GAC AGA AAG CGA CGT CNM 
NNM NNM NNM NNM NNM NNM NNC CTA GGA ACA TCA TC-5’ where N can be one 
of A, T, C, and G, whereas M can be either A or C. The designed primer sequence for 
extension was 5’- G ATG CTG TCT TTC GCT GCA G-3’. The primer and random 
oligonucleotides were annealed and extended to make complementary sequence of the 
random sequence. The extended DNA duplexes were double digested with BamHI and PstI 
and purified using polyacrylamide gel electrophoresis (PAGE). M13SK vector was double-
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digested using PstI and BamHI and dephosphorylated using Antarctic phosphatase. 
Dephosphorylated vector was ligated with double cut-DNA duplex at 16°C overnight, 
purified, and concentrated. (All enzymes were purchased from New England Biolabs.) 1 µl of 
concentrated ligated vector was electrotransformed into XL-1 blue, electro-competent cells at 
1.8 kV/cm, and total 10 transformations were used for library construction. Transformed cells 
were incubated for 45 min and fractions of several transformants were plated on IPTG-
XGal/TET agar to determine the diversity of the p8 library while the rest were amplified.  
 
b) Modified construction scheme to improved p8 library yield  
Even though the p8 library with a moderate degree of diversity was successfully 
constructed, diversity needs to be higher for more refined bio-panning experiment such as 
sorting metallic SWNTs versus semiconducting SWNTs. Moreover, the p8 library constructed 
has a high background of E4 (negatively charged) virus being 10% of the total virus 
concentration. This can be adverse in some cases for example, when p8 library is used to 
search peptide sequences binding to positively charged targets. The small size of the final 
DNA duplexes to be ligated to M13 viral vector is considered as the main hurdle to get higher 
diversity and negligible background because using PAGE to purify double-digested DNA 
gives only a yield of ~ 1% of starting DNA and the small size of double-digested inserts 
prevent efficient ligation. To address this problem, a BspH I restriction site can be chosen 
instead of Pst I. M13SK vector is a derivative of M13KE vector and the M13KE vector 
already has a BspH I restriction site. When utilizing this new restriction sites, the final DNA 
duplex length can be increased from 27 bp to 101 bp. The oligonucleotide sequences for the 
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restriction sites of Pst I and BspH I are 5’-TTA ATG GAA ACT TCC TCA TGA AAA AGT 
CTT TAG TCC TCA AAG CCT CTG TAG CCG TTG CTA CCC TCG TTC CGA TGC 
TGT CTT TCG CTG CAG -3’ (primer) and 5’-AAG GCC GCT TTT GCG GGA TCC NNM 
NNM NNM NNM NNM NNM NNM NCT GCA GCG AAA GAC AGC ATC GGA ACG 
AGG GTA GCA ACG GCT ACA GAG GCT TT-3’. By employing this new strategy, it will 
be possible to create a p8 library with higher diversity as well as minimized background.  
 
c) Construction of p8 library with biased peptide inserts 
P8 library with biased randomization of insert can be also a very powerful tool to find 
peptide sequences with desired functionality. For example, for enhanced interaction of 
peptides with metal ions, histidine (H) can be fixed within the peptide insert, and other 
positions can be randomized such as N-X’HXXXXXX’-C or N-X’XXHXXXX’-C schemes. 
This strategy increases the possibility to get right sequences. Another advantage of the biased 
library is that we can still have the same level of diversity with specific amino acid fixed on 
the desired position. The same level of diversity is possible because the maximum diversity of 
the library is in general limited by the electro-transformation efficiency, which is of about 108. 
The theoretical limit of the diversity of fully randomized peptide sequences is 5 × 206 × 
12=3.84 × 109 and for one fixed amino acid is 5 × 205 × 12=1.92 × 108: among eight mers, the 
first residue is fixed among 5 amino acids and the last residue among 12 amino acids due to 
the fixed codon sequence of either end.  
 
2.2.2. Complexation of M13 virus/SWNTs 
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a) Bio-panning with p8 phage-display peptide-library 
For the bio-panning experiment, SWNTs were prepared in a form of thin films on 
glass substrates (Fig.2.4) to maximize the direct contact of the virus to SWNT and a 
constructed p8 phage-display library was used. 10 µl of the library solution, 1010 viruses of 2 
×106 different p8 sequences, was diluted with 250 µl of Tris-buffered saline (TBS, 100 mM 
Tris-HCl, 150 mM NaCl, pH 7.5) with different concentration of Tween-20 (TBS-T, Tween-
20 concentration of 0.1-0.5 v/v%), and then was applied to SWNT-films and incubated for an 
hour with gentle rocking. The SWNT-film was rinsed with 1 ml of TBS-T ten times to wash 
off unbound virus. Bound viruses were eluted by 100 µl of 0.2 M Glycine-HCl, pH 2.2 and/or 
mid-log E.coli culture to harvest strongly bound virus not eluted by acid solution. The eluted 
viruses were amplified and the same procedures were repeated for further rounds with 
increasing detergent concentration. After each round of panning, the numbers of eluted and 
amplified virus, counted as PFU, were measured using agar plates containing X-gal/isopropyl-
β-D-1-thiogalactopyranoside (IPTG)/tetracycline. The input number of virus for each round 
was kept the same. Moreover, plaques from each round were amplified and DNA-sequenced. 
DNA sequencing was done in the Biopolymers laboratory at MIT. 
 
b) Screening of p8-modified M13 virus for stabilizing SWNTs  
In the screening experiment, each virus clone with different concentrations was mixed 
with sodium cholate (SC)-dispersed SWNTs in water and dialyzed against TBS (100 mM 
Tris-HCl, 150 mM NaCl, pH 7.5, Tween 0.3 v/v%) using 96-well microdialyzer 
(Spectralabs.) for three days with frequent buffer exchanges. SC-dispersed SWNTs without 
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any virus clones added were also dialyzed as a negative control. After the dialysis, each 
solution was harvested and transferred to a new 96-well plate for visual comparison.  
 
c) Calculation of the virus-to-SWNT ratio 
For M13 virus/SWNT complexation, the number of M13 virus and SWNTs were 
calculated first. The concentration of the virus was calculated using the empirical equation, 
(A269nm@1mm-A320nm@1mm) × 6 × 1017/#of base pair of the viral DNA (7234) = # of viral 
particles/ml (10). The concentration of CoMoCAT was calculated using the equation, 
A990nm@1cm×13= µg/ml  (15). For HipCO, an empirical equation, A632@1cm×27.8=µg/ml, was 
used. For 99% metallic and 99% semiconducting SWNTs, the starting concentration was 10 
µg/ml (NanoIntegris). For the calculation of the number of SWNT per µg of SWNT, we used 
1 µg of SWNT = 1.06 × 1012 assuming 0.8 nm in diameter and 500 nm in length (16). Since 
different SWNT solutions have different mean lengths, the actual number of SWNTs can be 
different for various SWNTs. The mean lengths of the SWNTs used are similar to or longer 
than 500 nm but still shorter than 1 µm, and therefore the calculated number of SWNT could 
be overestimated, but by a maximum of two times.  
 
d) Complexation of SWNTs with M13 virus without ‘pH switch’ method 
1 ml of P8cs#3 virus stock solution with a concentration of 1.4 ×1014/ml was mixed 
with 4 ml of SWNT with concentration of 40 µg/ml. The solution was dialyzed for three days 
using dialysis membrane, MWCO of 12,000 ~ 14,000 (SpectraLabs). The dialyzing condition 
is very critical to get a homogeneous and stable complex solution in a large volume with bag 
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dialysis. The dialyzing solution started with water with 10 mM NaCl and 0.64 mM NaOH. 
After the first three buffer exchanges, the ionic concentration of the buffer was step-wisely 
increased from 10 mM to 150 mM and phosphate-buffered saline (PBS) was used after 150 
mM water was used.    
 
e) Complexation of virus/SWNT with ‘pH switch’ method 
Various starting SWNTs were either prepared according to the previously reported 
methods or purchased from NanoIntegris. Calculated amount of SWNT-binding virus solution 
was mixed with the calculated volume of SWNTs dispersed by 2 wt% sodium cholate (SC) in 
water. The mixed solution was dialyzed against water (10 mM NaCl, pH =5.3) for two days 
with frequent solution changes. After two days of dialysis, the pH of the dialyzing solution 
was increased to ~10. A dialysis membrane, MWCO of 12,000-14,000 (SpectraLabs) was 
used for all dialysis procedure.  
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2.3. Results and discussion 
 
By using Pst I and BamH I enzymes to digest restriction sites, a p8 phage-display 
peptide-library with a diversity of 2 × 106 plaque-forming units (PFU) was successfully 
constructed. Diversity was confirmed by titration method after electro-transformation. The 
relatively lower diversity of p8 library compared to p3 one (commercially available p3 library 
has a diversity of ~109) is due to the more stringent requirements for the virus assembly 
process with p8 coat proteins. To confirm the randomization of the eight amino acids fused to 
the amino-terminus of p8 protein preceded by the first residue of p8 protein, A, plaques were 
randomly picked and DNA sequenced. In table 2.1, amino acid sequences of p8 proteins from 
randomly picked 20 plaques are shown. All the different p8 insert sequences confirm the 
successful incorporation of randomized peptide inserts. It is noted that there are two 
background sequences (10%) from parental vector (EEE or EEAE). However, these 
background viruses were removed after the second round of bio-panning against SWNTs and 
therefore this was not a problem for this work. The diversity of 2 × 106 with 10% background 
different peptide sequences is a reasonable diversity with which to conduct combinatorial 
screening experiment in the laboratory.  
For the bio-panning experiments, the method to harvest bound viruses has been 
modified from acid elution that is commonly used to disrupt peptide interaction to bacterial 
elution. When using a p3 library, it is possible to elute viruses bound through p3 inserts 
because there are only 5 copies of p3 coat proteins per viral particle. When using p8 library, 
however, it is difficult to elute viruses bound along the p8 coat proteins by using a non-
specifically interrupting acid elution method due to the multivalent interaction between 2,700 
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copies of M13 virus and SWNTs. To solve this problem, E. Coli has been utilized to identify 
DNA sequences of bound M13 viruses because only p3 proteins are required for E. Coli 
infection and the binding to SWNTs are made through p8 coat proteins. To minimize 
harvesting non-specifically bound M13 virus clones, E. coli elution was applied after acid 
elution.  
After several rounds of iterative panning against the SWNT film, consensus sequences 
were identified. In table 2.2, sequencing results are presented for both acid-elution and 
bacterial elution. Several interesting features can be concluded from the sequencing result. 
First, the acid-elution method gives sequences thought to amplify quite fast compared with 
others. Second, “LP or IP” epitope of the sequences are shown except in the highly 
amplifying sequences, DPSRLNAE and VPSAATSE, which are found in both elution 
methods (Leucine, L, and Isoleucine, I, possess quite similar properties). It is also interesting 
to note that the sequence DVYESALP has an aromatic residue, tyrosine, Y, in addition to LP 
and it appears more frequently than all the other sequences except DKSIEPLP and 
DSPRLNAE. Even though DKSIEPLP appears the most frequently, it is also found in acid-
elution method whereas DVYESALP is only found in the E.coli elution method.  
To test whether those sequences identified through the bio-panning experiment with 
p8 library can disperse SWNTs in aqueous solution, which is of interest to this work, a 
screening experiment was performed. For screening test, DPSRLANE, named p8CS#1, 
DKSIEPLP, named p8CS#2, and DVYESALP, named p8CS#3, were chosen. Each peptide 
sequence represent M13 virus with p8 proteins inserted with each sequence. If an M13 virus 
clone has a strong binding affinity toward SWNTs, it will disperse SWNTs even in the 
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absence of surfactants. That is, M13 virus can act as a ‘surfactant’ to disperse and stabilize 
SWNTs. After dialysis, only p8cs#3 formed a homogeneous solution with SWNTs whereas 
other clones and negative control formed black aggregates (Fig. 2.5). This solubility suggests 
that p8cs#3 had a binding affinity strong enough to disperse SWNTs in aqueous solution. It is 
interesting to note that the sequence p8CS#3 is the one from E. coli elution and did not appear 
in the acid-elution. Moreover, only p8CS#3 has an aromatic residue, tyrosine (Y), which is 
thought to preferentially interact with the graphene sidewall of carbon nanotubes (3,4). To 
further probe the binding mechanism of p8CS#3 to SWNTs, the hydrophobicity of the peptide 
sequence was calculated and plotted (Fig. 2.6) (17). The peptide insert of p8CS#3 has a 
hydrophobic moiety sandwiched within a hydrophilic region and this moiety interacts with 
SWNTs. Meanwhile, p8CS#1 lacked a hydrophobic region and p8CS#2 showed lower 
hydrophobicity than p8CS#3. In general, π-π stacking and hydrophobic interaction are 
considered to be the main interaction mechanisms between biological molecules and SWNTs. 
Therefore, it is reasonable to conclude that the combination of π-π stacking and hydrophobic 
property of the p8CS#3 sequence is the driving force for the SWNT binding. Even though the 
hydrophobic moiety is small, the overall interaction between SWNT and the virus is amplified 
by multivalent binding, as each M13 virus has 2,700 copies of p8 major coat protein that form 
well ordered structures with five-fold-symmetry and two-fold screw symmetry about the 
major axis. Based on the crystallographic data of wild-type M13 virus (PDB ID: 2C0W), 
there are about 31 p8 peptides in series per 100 nm along the virus. This multivalent and 
cooperative binding scheme makes detachment of SWNT off the virus unlikely. 
  36 
To produce a large amount of virus/SWNT complex solution, a bag-dialysis method 
instead of 96-well microdialyzer was employed. During the dialysis, however, it was found 
that the ionic strength of dialyzing solution and the surface charge of M13 virus were also 
critical to get stable complex solutions. For example, when the ionic strength of dialyzing 
solution decreased, the integrated photoluminescence (PL) intensity of the complex solution 
increased. Moreover, when more negative charges were induced on the surface of M13 clone, 
the integrated PL decreased. Since bundled SWNTs lowers PL efficiency (2), lower ionic 
strength and less negative surface charge is more advantageous for better-dispersed SWNTs. 
These results imply that electrostatic interaction both between SWNTs and between M13 
virus and SWNT is also critical during complexation in addition to the binding affinity of 
M13 clone toward SWNTs. The surfaces of SWNTs initially dispersed by SC are negatively 
charged due to the non-covalently adsorbed cholate ions. Because p8cs#3 is negatively 
charged at pH of DI water (~6) (pI of p8cs#3 is around 4.3) (Fig. 2.7), p8cs#3 and cholate-
SWNTs repel each other at the early stage of complexation. At later time course, p8cs#3 can 
bind SWNTs but in this case, SWNTs can also find each other and form bundles because 
excess cholate ions have been dialyzed away. This is critical because the number of M13 
virus (‘surfactant’) is smaller than the number of SWNTs for the surfactant exchange of 
SWNTs with M13 virus, which is not the case when utilizing small coating molecules for 
surfactant exchange (18).  
Based on this understanding, an M13 virus clone with p8 insert sequence of 
DSPHTELP was chosen for improved complexation with SWNTs. This sequence was also 
identified through bio-panning against SWNTs (Table. 2.2). The sequence has an aromatic 
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residue, histidine (H), which is expected to interact with the sidewall of SWNTs through π-π 
stacking at all pH ranges. Moreover, the pKa of the side chain of histidine is around 6 and 
therefore histidine in the selected sequence allows us to neutralize the surface of the virus 
without disrupting the virus stability. To minimize the initial electrostatic repulsion between 
the virus and SWNT, thus facilitating the binding of SWNT by virus, the pH of the dialyzing 
solution was set to the pI of the virus, 5.3 (Fig. 2.7). After the complexation was completed, 
the pH of the complex solution was increased to around 10, at which point the zeta potential 
of the virus becomes around -35 mV. This increased negative surface charge of the virus is 
advantageous for the colloidal stability (19) of the complexes as well as for the nucleation of 
inorganic materials on the complex template. Using histidine as a ‘pH-switch’, the repulsion 
between the virus and the SWNT is reduced while the electrostatic repulsion between cholate-
SWNTs still exists in the early stage of the complexation, minimizing possible small bundling 
of SWNTs. By utilizing this method, SWNTs complexed with the virus retained about 82% of 
the integrated (935 – 1,250 nm) PL intensity of starting SWNTs for CoMoCAT (Fig. 2.8). 
Therefore it can be concluded that the virus with the peptide sequence selected allows for 
efficient binding and dispersion of SWNTs through pH-dependent control.  
To visualize the bound SWNT along the major coat proteins of the virus, high-
resolution transmission electron microscopy (HRTEM) was used (Fig. 2.9). Part of the virus 
major coat proteins has been intentionally burned off during imaging, clearly identifying 
bound SWNT. Since the SWNT-binding peptides are expressed on the amino terminus of p8, 
SWNTs can interact with the SWNT-binding peptides along the grooves. In addition, because 
SWNT-binding peptides are inserted to the amino-terminus of p8 protein of wild-type M13, 
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the amino-terminal peptides of p8 engineered M13 virus are longer and more flexible than 
wild-type M13. These longer and flexible amino terminal peptides can moderately reorganize 
to maximize the π-π stacking and hydrophobic interactions between the SWNT-binding 
peptides and SWNTs while minimizing the surface exposure of hydrophobic SWNT surface.  
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2.4. Conclusion 
 
In this chapter, a biological toolkit, p8 library, has been constructed. Various M13 
clones with binding affinity toward SWNTs have been identified and screened for stabilizing 
SWNTs in aqueous solutions. A ‘pH switch’ method has also been developed to effectively 
bind and stabilize SWNTs with histidine-expressing M13 virus. With these developed 
methods along with the versatility of M13 virus, SWNTs can be successfully incorporated 
into various hybrid materials systems for energy devices and biomedical applications, to be 
shown in later chapters. 
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2.5. Figures and Tables 
 
Fig. 2.1. Schematic of a SWNT. a, SWNT as a rolled-up sheet of graphene. b, Electronic 
density of states of SWNTs. E11 corresponds to the energy of photoluminescence from 
semiconducting SWNTs.  
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Fig. 2.2. M13 virus as a versatile biological toolkit. a, A schematic of M13 virus with 
various capsid proteins indentified. b, Cloning vector (M13SK) of M13 virus used for the 
construction of p8 phage-display peptide-library. c, Residues and copies of various capsid 
proteins of M13 virus. d, A schematic of M13 virus with randomized p8 insert 
(X’XXXXXXX’) shown. e, Cross-sectional view of helically assembled p8 coat proteins. 
PDB ID:2C0W. 
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Fig. 2.3. P8 phage-display peptide-library construction. a, Scheme of p8 library 
construction. In the library presentation, each color represents different p8 insert. b, Peptide 
representation of p8 library construction. c, DNA duplex sequences for p8 inserts.  
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Fig. 2.4. Preparation of SWNT films for bio-panning against SWNTs. a, Preparation of 
SWNT film. b, Scheme of target samples for bio-panning.  
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Fig. 2.5. Screening of p8-modified virus clones for stabilizing SWNTs. a, The upper 
column has the highest virus concentration and each virus clone has duplicate samples. Only 
clone p8cs#3 shows homogeneous solutions while others form black aggregates. b, Dialysis 
result for SWNT dialyzed with and without virus clone p8cs#3. After 24 h, black aggregates 
are clearly observed for SWNTs dialyzed without virus. p8cs#1:DPSRLNAE, 
p8cs#2:DKSIEPLP, p8cs#3:DVYESALP.  
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Fig. 2.6. Hydrophobicity as a function of the amino acid location of various sequences. a, 
p8cs#3 (DVYESALP). b, comparison of the hydrophobicity plots of p8cs#1 (DPSRLANE), 2 
(DKSIEPLP), and 3. The plot was calculated based on Hopp-Woods scale and the averaging 
group size was 5. The calculation included alanine located at the N-terminus of p8 protein and 
3 more residues, DPA followed by the random 8-mer peptide, that is, A(X)8DPA, is used for 
the calculation where (X)8 corresponds to the sequences of p8cs#1, 2, and 3. 
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Fig. 2.7. Zeta potential of DVYESALP and DSPHTELP clones. pI of DVYESLP clone is 
~4.3 while that of DSPHTELP clone is about 5.3.  
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Fig. 2.8. The effect of pH-switch on complexation. The integrated PL intensity (935 nm ~ 
1,250 nm) for the complexes made with pH-switch method increases by 2.8 times, implying 
better dispersion of SWNTs. For with_pH-switch samples, the pH of the dialyzing solution 
was set as 5.3 (pI of the virus) and then increased to 10 after the complexation. In contrast, for 
the without_pH_switch complexes, the pH of the dialyzing solution was kept as 10 during and 
after the complexation. The virus-to-SWNT ratio is 1:1 for both complexes and the final 
solution is PBS. CoMoCAT SWNTs were used for the complexation and all the peaks are 
assigned.  
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Fig. 2.9. High-resolution transmission electron microscopy of M13-SWNT complex. M13 
virus is guided by dotted line and SWNT is indicated by an arrow.  
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
  49 
Table 2.1. Sequencing result of p8 inserts from randomly picked plaques of primary p8 
library. 
 
V D P Y A E S M 
A S S P S T F E 
G M T S T D G G 
G S E M A S H P 
D D H D S K L P 
A D S D S G Q T 
A T G H S P D P 
G H L S A S E S 
G P N E S S Y S 
D S R P P D L S 
D M T P P N M S 
D P P M S S S S 
G A D G H I E P 
A P G A T S G L 
D Y L P S S P P 
E E E      
A N S Q H W D T 
D D L A T A Q T 
E E A E     
V A Q M V A P E 
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Table 2.2. Sequencing result for p8 inserts from bio-panning experiment against 
SWNTs-films. Sequences from two different elution methods are presented. The first amino 
acid residue is preceded by, A, located at the amino terminus of p8 protein of M13 virus. 20 
plaques were sequenced for the Acid_elution and 40 plaques, for the E. Coli_elution.  
 
                                                             Acid_elution 
D P S R L N A E 12/20 
V P S A A T S E 3/20 
V S Q P L A S E 2/20 
D K S I E P L P 2/20 
V P A N P S E G 1/20 
 
                                                           E. Coli_elution 
D K S I E P L P 23/40 
D P S R L N A E 6/40 
D V Y E S A L P 3/40 
V P S A A T S E 2/40 
D S P H T E L P 1/40 
E V A P A A L P 1/40 
D Q P S P S L P 1/40 
D P G P S S I P 1/40 
G G E T P S L P 1/40 
A S T A D L A P 1/40 
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Chapter 3. Fabricating high-power lithium-ion 
batteries using multiple virus genes 
 
 
 
 
 
 
 
 
 
  54 
3.1. Abstract 
 
Development of materials that deliver more energy at high charge/discharge rates is 
important for high power applications including portable electronic devices and hybrid 
electric vehicles. Here, a strategy for attaching electrochemically active materials to 
conducting carbon nanotubes networks through biological molecular recognition is 
introduced. By manipulating two-genes of the M13 virus, viruses were equipped with peptide 
groups with affinity for single-walled carbon nanotubes (SWNTs) on one end and peptides 
capable of nucleating amorphous iron phosphate (a-FePO4) fused to the viral major coat 
protein. For the virus clone that demonstrated 10 times greater affinity towards SWNTs, 
power performance of a-FePO4 was comparable to that of crystalline lithium iron phosphate 
(c-LiFePO4). The electrodes showed excellent capacity retention upon cycling at 1C for at 
least 50 cycles. This environmentally benign low temperature biological scaffold could 
facilitate fabrication of electrodes from materials that have been excluded because of their 
extremely low electronic conductivity. 
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3.2. Introduction 
 
Lithium ion battery electrodes store and release electrical energy by insertion and 
extraction of Li+ ions and electrons through the electrode materials. Therefore, increasing 
transport of Li+ ions and electrons in electrodes can enhance energy storage at high charge 
and discharge rates. Controlling nanostructure has become a critical process in developing 
electrode materials to boost transport in composite electrodes (1, 2) especially for the 
electrically insulating transition metal phosphate cathode materials.  Among them, iron 
phosphate based materials have elicited attention as promising Li ion battery positive 
electrode materials due to their lower toxicity, lower cost, and improved safety through 
improved chemical, thermal, and structural stability for high power applications (3). However, 
their practical use has been constrained due to kinetic limitations, which result in poor charge 
and discharge rate capability and fading of capacity upon prolonged cycling. To address the 
rate limitation of these materials, most researchers have focused on tailoring particle size (4, 
5) to reduce both the ionic and electronic path within the particles and enhancing electronic 
conductivity with surface carbon coating layers (6) or conducting nanoparticles additives (7, 
8). However, the fabrication of nanosized particles is still challenging since the materials 
require at least 350°C for crystallization and carbon coating. Despite the recent advances in 
novel synthesis, the smallest particle size remains 20-40 nm (5). 
Biological systems offer capabilities for environmentally benign materials synthesis. 
An M13 virus-based biological toolkit has been developed for the design of nanoarchitectured 
structures and materials (9-12). Our group has shown that M13 bacteriophage (phage or virus) 
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can be used for battery device fabrication with improved performance by synthesizing 
electrochemically active anode nanowires and organizing the virus on a polymer surface (11, 
13). However, in designing nanostructured electrodes with better electrical wiring for high 
power batteries, multifunctionality of the virus is required. Multifunctional viruses have been 
engineered with desired modifications on different positions of the protein coat (10, 12, 14). 
Here we demonstrate a genetically programmed multifunctional virus as a versatile scaffold 
for the synthesis and assembly of materials for high power batteries. 
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3.3. Experimental  
 
P3 phage-display peptide-library screening against SWNTs  
As-prepared HiPCO (HPR 111.1 from Rice University) single-walled carbon 
nanotubes (SWNTs) were used in this study. SWNTs were suspended in water with 2 wt% 
sodium cholate (SC) surfactants and sonicated, followed by ultra-centrifugation to disperse 
suspended SWNTs individually in a similar way reported previously (15). The final 
concentration of SWNTs-solution was adjusted to be 0.005 w/v%. For the phage-display 
experiment, SWNTs were prepared in a form of thin films on glass substrates and a 
commercially available 12-mer phage-display library kit (Ph.D.-12TM Phage Display Peptide 
Library Kit, New England Biolabs) was used. In brief, 10 µl of phage-library solution (viruses 
of 1.5 × 1010 with 2.7 × 109 different sequences) were diluted with 250 µl of Tris-buffered 
saline (TBS, 100 mM Tris-HCl, 150 mM NaCl, pH 7.5) with different concentration of 
Tween 20 (TBS-T, Tween 20 concentration of 0.1-0.5 v/v%), applied to SWNTs films and 
incubated for 1 h with gentle rocking. The SWNTs film was rinsed with 1 ml of TBS-T ten 
times to wash off unbound viruses. Bound viruses were eluted by incubating with 100 µl of 
0.2 M Glycine-HCl, pH 2.2, for eight minutes and carefully transferred into a 1.5 ml-
microcentrifuge tube and immediately neutralized with 15 µl of 1 M Tris-HCl, pH 9.3. The 
eluted viruses were amplified and the same procedures were repeated for further rounds with 
increasing Tween 20 concentration. After each round of panning, the numbers of eluted and 
amplified viruses counted as plaque-forming units (PFU) were measured using agar plates 
containing X-gal/isopropyl-β-D-1-thiogalactopyranoside (IPTG)/tetracycline to set the input 
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number of virus for each round the same. Also plaques from each round were amplified and 
DNA sequenced.   
 
Binding affinity test 
In the binding test, viruses with the same input number of 5 × 108 PFU, diluted with 
250 µl of TBST 0.3 (TBS, 100 mM Tris-HCl, 150 mM NaCl, pH 7.5, Tween 0.3 v/v%), were 
incubated with SWNTs films for one hour with gentle rocking. Then, the SWNTs film was 
rinsed with 1 ml of TBST 0.3 ten times to remove unbound viruses. Bound viruses were 
eluted by incubating with 100 µl of 0.2 M Glycine-HCl, pH 2.2, for 8 min, carefully 
transferred into 1.5 ml-microcentrifuge tube and immediately neutralized with 15 µl of 1 M 
Tris-HCl, pH 9.3. The eluted virus-solutions were serially diluted and plated on agar plates 
containing X-gal/isopropyl-β-D-1-thiogalactopyranoside (IPTG)/tetracycline. The plates were 
incubated at 37 ºC overnight and the numbers of eluted viruses were counted as PFU from 
blue plaques.  
 
Genetic engineering of multifunctional M13 virus 
For the E4 virus, tetraglutamic acids were engineered onto the N-terminus of pVIII 
protein of M13 as previously described (16). The oligonucleotide pairs used for EC#1 and 
EC#2 were 5’-GTA CCT TTC TAT TCT CAC TCT CAT GGT CAT CCG TAT CAG CAT 
CTT CTG CGT GTG CTG GGT GGA GGT TC-3’, 5’-GGC CGA ACC TCC ACC CAG 
CAC ACG CAG AAG ATG CTG ATA CGG ATG ACC ATG AGA GTG AGA ATA GAA 
AG-3’ and 5’-GTA CCT TTC TAT TCT CAC TCT GAT ATG CCG CGT ACT ACT ATG 
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TTC CGC CGC CGC GTG GTG GAG GTT C-3’, 5’-GGC CGA ACC TCC ACC ACG CGG 
CGG CGG AGA CAT AGT AGT ACG CGG CAT ATC AGA GTG AGA ATA GAA AG-
3’, respectively. The oligonucleotides were synthesized, phosphorylated (Operon 
Biotechnologies) and annealed to form DNA duplexes. The E4-virus vectors were extracted 
from E4 virus using miniprep kit (QIAprep Miniprep, QIAGEN) and double-digested with 
Acc65 I and Eag I. Double-digested vectors were purified by means of agarose-gel 
electrophoresis, dephosphrylated with Antarctic phosphatase and ligated with DNA duplexs 
(All enzymes were purchased from New England Biolabs.). Ligated vectors were 
electrotransformed into XL-1 blue electrocompetent cells (Stratagene) and incubated at 37ºC 
for an hour and plated. The inserted gVIII and gIII genes were confirmed by DNA 
sequencing. DNA sequencing was done in MIT Biopolymers lab.   
 
 
 
 
 
 
 
 
 
 
 
  60 
3.4. Results and discussion 
 
Virus-enabled nanostructured cathode materials were first demonstrated by templating 
amorphous anhydrous iron phosphate (a-FePO4) on the E4 virus. E4 is a modified M13 virus 
that has tetraglutamate (EEEE-) fused to the N-terminus of each copy of p8major coat protein. 
Due to the presence of extra carboxylic acid groups compared with wild-type M13 virus 
(M13KE), the E4 virus exhibits increased ionic interactions with cations, and can serve as a 
template for materials growth (10, 13, 16). Since only one gene (gVIII) has been modified for 
the desired peptide motif on p8, we call this E4 clone a one-gene system. Amorphous iron 
phosphate nanowires were produced on silver nanoparticles (Ag NPs) loaded E4 virus. Even 
with this one gene system, the nanostructuring of a-FePO4 nanowires by the virus enabled an 
enhanced performance. However, high power performance and capacity retention upon 
cycling of both the biologically and traditionally synthesized electrodes are still inferior to 
commercially available c-LiFePO4 cathodes. Since the particles were already 10-20 nm in 
diameter, our strategy for improved performance was to improve the electronic conductivity 
in the cathode by achieving better electrical contact between the active materials. Although 
metallic Ag nanoparticles can enhance the electronic conductivity locally, more important for 
improved high power performance is a percolating network throughout the electrodes.  
It is known that incorporation of well-dispersed materials with high conductivity and 
high aspect ratio leads to efficient percolating networks (17, 18). Carbon nanotubes (CNTs) 
have been shown to meet these needs (18), thus well-dispersed single wall CNTs (SWNTs) in 
water were used. However, conventional composite electrode fabrication processes inevitably 
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suffer from aggregation of carbon particles thereby diminishing contact with the active 
materials (18). To achieve better electrical wiring to our biologically derived a-FePO4, a 
specific affinity was engineered between the conducting material and active material.  
Since the major coat protein of the E4 virus serves only as a template for a-FePO4 
nanowires growth, additional genetic modification was required to engineer the E4 virus to 
have a binding affinity for SWNTs. In this context, the p3 protein, a minor coat protein 
located at one end of the virus (Fig. 3.1), is an ideal tool since gene III can be independently 
controlled from gene VIII to insert foreign DNA encoding p3-displayed peptides. Moreover, 
the peptide sequences identified through the phage-display with a p3 phage-display library 
can be directly inserted into the E4 virus without losing functionality (12). Therefore, phage-
display experiments to search for peptide sequences with a strong binding affinity for SWNTs 
were done first, and then genetic engineering into the E4 virus to produce a multifunctional 
virus structure. Several consensus sequences were obtained from separate phage-display 
screening experiments. Among them, sequences N’-HGHPYQHLLRVL-C’, named as MC#1, 
and N’-DMPRTTMSPPPR-C’, as MC#2, were selected for further experiments. The sequence 
MC#1 started with histidine (H), whose appearance in the first position was often observed in 
CNTs-binding sequences (19). Also it contained several aromatic residues (H and Y), which 
were expected to favorably bind to graphene surface via π-π stacking interaction (20). The 
sequence MC#2 is quite different from MC#1 and the clone MC#2 showed approximately 
four times higher binding affinity than the clone MC#1 whose binding affinity is already two 
and a half times higher than wild-type M13KE in the binding affinity tests (21). (Fig. 3.2) The 
strong binding of the sequence MC#2 can be explained by the location of the hydrophobic 
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segments of the sequence. The calculated hydrophobicity plot (Fig. 3.3) shows a tri-block 
structure with hydrophilic regions on both ends and the hydrophobic region in the middle of 
the sequence. It has been demonstrated that a tri-block structure of 
hydrophilic/hydrophobic/hydrophilic polymers worked well to suspend SWNTs (19, 22). 
To genetically engineer E4 virus as a multifunctional biological platform, the selected 
sequences, MC#1 and MC#2, were independently fused onto the amino-terminal portion of 
the p3 of E4 virus, producing clones EC#1 and EC#2 respectively. Since two genes (gIII and 
gVIII in Fig. 3.1) have been engineered with desired modification on both p3 and p8 proteins, 
we called it a two-gene system. All viruses were loaded with Ag NPs to synthesize anhydrous 
a-FePO4. Formation of anhydrous a-FePO4 on the p8 preceded the interaction with SWNTs. 
The synthesis procedure of anhydrous a-FePO4 nanowires on the multifunctional viruses was 
the same for the growth on the one-gene system. Viral a-FePO4 solutions were then incubated 
with the SWNT suspensions to form a-FePO4/SWNTs hybrid nanostructures.  
The morphology of hybrid a-FePO4/SWNTs nanowires on the EC#2 virus is shown in 
Figure 3.4. In the high-resolution TEM image, 6~8 SWNTs are bundled with diameters of 4-5 
nm. The TEM images show that a-FePO4 nanowires templated on the multifunctional virus 
were tethered to SWNTs mainly through the p3 attachment, however, they made multiple 
contacts with neighboring SWNTs due to close positioning. To explore the effect of 
specificity, we also mixed the one-gene system (E4) viral nanowires solution with SWNTs. 
Most viral a-FePO4 nanowires on E4 did not make contact with SWNTs, and even if they did, 
the contact did not seem to be specific binding with SWNTs (Fig. 3. 5). Moreover, SWNTs 
aggregated by themselves when there was no specific binding affinity on p3, suggesting that 
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SWNTs specific viruses enhanced dispersion of SWNTs in solution. Similar observation has 
been reported showing that SWNTs specific peptides can disperse SWNTs while non-specific 
pepetides cannot (19). 
The electrochemical properties of viral a-FePO4/SWNTs hybrid materials with 5 wt% SWNTs 
were evaluated and compared (Fig. 3. 6). As demonstrated in the first discharge profiles (Fig. 
3.6 and Fig. 3.7 for full discharge/charge curves), electrochemical performances show 
remarkable improvement as the binding affinity to the SWNTs increases. Specific capacity at 
a low discharge rate of C/10 increased from 143 mAh/g (E4) to 160 mAh/g with EC#1 and to 
170 mAh/g with EC#2.  The performance improvement is more pronounced at higher rates. 
Discharge profiles of the two-gene system show much lower polarization and maintain much 
higher capacity than those of the one-gene system at high rates. When compared with the best 
reported capacity for a-FePO4 at a high rate of 3C (80 mAh/g) (23), EC#2 showed a capacity 
of 134 mAh/g confirming substantially improved high power performance. Moreover, when 
we cycled EC#2 between 1.5 and 4.3 V, the first discharge capacity at 10C reached 130 
mAh/g. No published data for a-FePO4 is available to compare with at a rate higher than 3C, 
but this capacity value obtained for the two-gene system is comparable to the capacity from 
state-of-the-art c-LiFePO4. The power performance of the multifunctional virus based cathode 
was further compared using a Ragone plot. Figure 3.6 shows that two-gene system based 
materials delivered much higher energy than the one-gene system at high power. At a specific 
power of 4000 W/kg (approximately corresponds to a rate of 10C), the energy density of 
EC#1 and EC#2 was two times and three times higher respectively than that of E4. Again, the 
high power performance scales with binding affinity. In Figure 3.6 inset, rate performance of 
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E4 virus based cathodes with either Super P carbon or SWNTs were tested. It is well known 
that well-dispersed SWNTs by themselves make better electrical wiring to active materials 
due to better percolation networks than carbon black powders, confirming the importance of 
nanoscale electrical wiring. Figure 3.6 C shows stable capacity retention of a-FePO4/SWNTs 
hybrid electrodes upon cycling at 1C. Up to 50 cycles, there was virtually no capacity fade 
observed. A slight capacity loss after the first cycle is a characteristic of a-FePO4 materials 
(23, 24). When cycled at C/10 rate again after the sample was tested for several cycles at rates 
from C/10 to 10C, the original capacity was recovered confirming structural stability (Fig. 
3.7B). Structural stability of viral a-FePO4/SWNTs hybrid nanostructures was induced by 
materials specific binding and stiff/robust carbon nanotubes and brought about excellent 
retention at low SWNTs content of 5wt%.  Since the density of SWNTs is 1.33 g/cm3, it 
would decrease the volumetric energy density of the hybrid electrodes. However, although we 
adopted SWNTs to show that we can do nanoscale wiring by using genetic engineering, we 
expect that we could optimize the fraction of the conducting additives by using even better 
conducting nanowires with high aspect ratio and higher density.  
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3.5. Conclusion  
 
In this work, by developing a two-gene system with a universal handle to pick up 
electrically conducting carbon nanotubes, we facilitated a method to realize nanoscale 
electrical wiring for high power lithium ion batteries using basic biological principles. This 
biological scaffold could further extend possible sets of electrode materials by activating 
classes of materials that have been excluded because of their extremely low electronic 
conductivity. This versatile platform could also be conjugated with Li-containing positive 
electrodes.  
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3.6. Figures 
 
Fig. 3.1. Biological toolkits: genetic engineering and biomolecular recognition. (A) A 
schematic presentation of the multifunctional M13 virus is shown with its important proteins 
genetically engineered in this study. (B) A schematic diagram for fabricating genetically 
engineered high power lithium ion battery cathodes using multifunctional viruses (two-gene 
system) and a photograph of actual battery used to power a green light-emitting diode (LED).  
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Fig. 3.2. Binding affinity comparison. (A) Binding affinity for single-walled nanotubes 
(SWNTs) of various viruses with different peptide inserts on the p3 was compared by the 
number of plaque-forming units (PFU). The PFU number is proportional to the binding 
affinity. The M13KE has no insert on its p3 while virus clones MC#1 and MC#2 display 
peptides N’-HGHPYQHLLRVL-C’ and N’-DMPRTTMSPPPR-C’ on the p3, respectively. 
(B) Digital camera images of the titration result. The individual blue plaques correspond to 
bacteria infected by one active virus particle and the number of plaques gives the count of 
active virus particles  
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Fig. 3.3. Hydrophobicity as a function of amino acid location of the sequence EC#2, N’-
TMPRTTMSPPPRC’. The plot was based on Hopp-Woods scale with the averaging group 
length of five. Here, positive values correspond to hydrophobic regions while negative values 
represent hydrophilic regions. The hydrophobicity plot shows a tri-block structure with 
hydrophilic regions at both ends of the sequence. Here a three glycines (GGG)-linker 
sequence was also considered to fully calculate the hydrophobicity.    
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Fig. 3.4. Morphology of the a-FePO4 grown on the multifunctional viruses/SWNTs 
hybrid nanostructures. TEM images of the following. (A) a-FePO4 nanowires templated on 
EC#2 viruses (before interacting with SWNTs). EC#2 virus is a two-gene system virus with 
the strongest binding affinity to SWNTs. (B) SWNTs only (before interacting with viral a-
FePO4).(C)-(E), a-FePO4 grown on EC#2 attached to SWNTs. (C) Low magnification 
(10,000). (D) Higher magnification (30,000). (E) High resolution TEM (HRTEM) images 
(800,000). For HRTEM imaging, surfactants were removed by washing with acetone. 
Material specific tethering of the viral a-FePO4 to the SWNTs is visualized. Amorphous 
nature of FePO4 was also confirmed.  
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Fig. 3.5 TEM images of the one-gene system a-FePO4 viral nanowires that were mixed 
with SWNTs without specific affinity. (A) a-FePO4 nanowires did not appear to make 
contact with SWNTs. (B) a-FePO4 nanowires that were in close proximity to SWNTs but do 
not contact with SWNTs. (C) a-FePO4 nanowires seen in contact with aggregated SWNTs 
bundles. SWNTs were not well dispersed but were aggregated with each other. 
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Fig. 3.6. Electrochemical properties of the a-FePO4 viral nanowires in two-gene systems 
tested between 2.0 and 4.3 V. Rate capabilities and capacity retention upon cycling of the a-
FePO4 nanowires/SWNTs hybrid electrodes templated on different clones are presented. All 
a-FePO4/SWNTs hybrid materials had 5 wt% SWNTs. (A) First discharge curves at different 
rates. (B) Ragone plot. Inset: Comparison of rate capability of E4 virus based cathodes with 
either Super P carbon or SWNTs. (C) Capacity retention for 50 cycles at 1C rate. There was 
no obvious fading for at least 50 cycles.  
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Fig. 3.7. Electrochemical properties of the a-FePO4 viral nanowires in two-gene systems 
tested between 2.0 and 4.3 V. (A) Full discharge/charge curves at rates of C/10, 1C and 10C. 
(B) Specific discharge capacity upon cycling at different rates; C/10, 1C, 10C and C/10. 
Electrodes using multifunctional viruses showed stable capacity retention upon cycling and 
recovery of original high capacity when cycled at C/10 rate again.  
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Chapter 4. Biologically self-assembled single-
walled carbon nanotubes for highly efficient 
electron collection in photovoltaic devices 
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4.1. Abstract 
 
The performance of photovoltaic devices can be improved by using rationally-
designed nanocomposites with high electron mobility to efficiently collect photo-generated 
electrons. Single-walled carbon nanotubes (SWNTs) exhibit very high electron mobility, but 
the incorporation of such nanotubes into nanocomposites to create efficient photovoltaic 
devices has been challenging. In this work, the synthesis of SWNT-TiO2 nanocrystal core-
shell nanocomposites using a genetically engineered M13 virus as a template is reported. By 
using the nanocomposites as photoanodes in dye-sensitized solar cells (DSSCs), it is 
demonstrated that even small fractions of nanotubes improve the power conversion efficiency 
by increasing the electron collection efficiency. It is also shown that both the electronic type 
and degree of bundling of the nanotubes in the SWNT/TiO2 complex are critical factors in 
device performance. With this approach, a power conversion efficiency in the dye-sensitized 
solar cells of 10.6% has been achieved. 
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4.2. Introduction 
 
Preserving non-renewable energy and lowering carbon dioxide emission requires 
efficient and inexpensive approaches to utilize solar energy. Nanoporous solar cells are 
promising due to lower cost and potentially higher efficiency than silicon solar cells, enabled 
by high internal quantum efficiency (1), large surface-to-volume ratio (2), and tunable 
absorption range (3, 4). However, in some cases fast recombination and slow carrier diffusion 
in nanoporous photovoltaic devices result in low power conversion efficiency. Various 
methods have been investigated to increase the power conversion efficiency of nanoporous 
solar cells by improving the incident photon-to-current conversion efficiency (IPCE). While 
increasing light absorption and charge separation efficiency have been studied widely (3, 6-
10), improving photoelectron collection efficiency has been reported only in a few papers 
(11). Most of them are devoted to developing materials with higher electron mobility and/or 
nanostructures with facilitated electron paths, such as vertical nanotube/nanowire arrays (12, 
13). Increasing electron diffusion length by changing materials or nanostructures, however, 
alters other important material and device properties such as charge separation and 
recombination, and surface area of thin films. Thus far, a method capable of increasing 
electron diffusion length while keeping other essential device physics parameters unaffected 
is absent.  
Making nanocomposites from combinations of materials, each with its unique 
functional advantage, is another approach to improve electron collection. Single-walled 
carbon nanotubes (SWNTs) have been regarded for a long time as a promising component for 
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nanocomposite photoanodes in photovoltaic devices (14, 15) because of their excellent 
electron mobility and one-dimensional shape (16). However, no report has shown pronounced 
improvement in power conversion efficiency of SWNT-incorporated solar cells due to several 
factors. First, as-produced SWNTs are an ensemble of metallic and semiconducting SWNTs. 
While semiconducting SWNTs can provide efficient electron diffusion paths without 
recombination, metallic components provide short-circuit paths, negating any possible 
improvements. Moreover, the strong tendency for SWNTs to form bundles (17) creates 
contact between SWNTs, transferring electrons from semiconducting SWNTs to metallic ones 
(18). Chemical modifications (19) and surfactants (14, 15) have been used to prevent SWNT 
bundling, but these methods either deteriorate the electronic properties (20) of SWNTs or 
make the heterogeneous nucleation of nanocrystals on SWNTs difficult. Therefore, it is 
desirable to develop methods to incorporate SWNTs in photovoltaic devices effectively. 
M13 virus is a filamentous bacteriophage which can be genetically engineered to 
express peptides selected for materials (21-23). Here we present a general and programmable 
method to integrate SWNTs into photovoltaic devices for highly efficient electron collection 
using M13 viruses as biological templates. Importantly, this method does not significantly 
affect electron transfer between semiconducting nanocrystals and SWNTs nor change the 
pristine properties of SWNTs. SWNTs are bound along the genetically engineered M13 
viruses and dispersed. In our virus/SWNT complex scheme, part of the SWNT surface is 
exposed to water, enabling a direct contact between biomineralized inorganic nanocrystals 
and SWNTs. Moreover, nanocrystals templated on viruses aid the complete encapsulation of 
SWNTs, which is challenging to realize with surfactant-dispersed SWNTs. 
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4.3. Experimental 
 
Preparation of starting SWNTs  
1) HiPCO and CoMoCAT solutions 
Raw HiPCO or CoMoCAT nanotubes were purchased from Unidym (R-SWNT, 
batch# R0513) and Sigma-Aldrich (product# 704148), respectively. Both HiPCO and 
CoMoCAT SWNTs were first mixed with distilled water with 2wt% sodium cholate (SC). For 
HiPCO SWNTs, the mixture was homogenized for 1 h and coup-horn sonicated for 10 min at 
90% amplitude, while CoMoCAT SWNTs were probe-tip sonicated for 2 h at 40% amplitude. 
The resulting solutions were centrifuged at 22oC and 30,000 rpm for 4 h to obtain individually 
dispersed SWNTs.  
 
2) 99% metallic SWNTs (IsoNanotubes-M TM) and 99% semiconducting SWNTs 
(IsoNanotubes-S TM) were purchased from NanoIntegris in a solution form. The as-received 
SWNT solutions were dialyzed against 2wt% SC aqueous solution before complexation with 
the virus.  
 
3) (6,5)-enriched SWNTs  
Separation of (6,5)-enriched SWNTs, based on density difference, was performed 
using a modified density gradient procedure from the literature (24). CoMoCAT SWNTs in 
2wt% SC aqueous solution was first mixed with 2 wt % sodium dodecyl sulfate (SDS) 
solution to a final ratio of SDS:SC = 1:4. A density gradient was made using a non-ionic 
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medium, iodixanol (OptiPrep, 60 w/v% iodixanol, Sigma-Aldrich). The concentration of 
initial gradient was adjusted to be 15, 20, 25 30 w/v% with a volume of 6 ml, and was 
positioned on top of 60 w/v% stop layer solution with a volume of 3 ml. All iodixanol layers 
contained 2 wt% surfactant in a ratio of SDS:SC = 1:4. Four ml of 1:4 SDS:SC SWNT 
solution was added on the top of the gradient, and was centrifuged at 22oC and 32,000 rpm for 
12 hours. The resulting gradient was fractionated at every 250 µl after centrifugation using a 
fraction recovery system (Beckman Coulter), and characterized by UV-vis-NIR absorption 
spectroscopy and fluorescence. Fractions enriched in the (6,5) nanotube species were 
collected and dialyzed against 2wt% SC aqueous solution. 
 
Calculation of the virus-to-SWNT ratio 
The concentration of the virus was calculated using an empirical equation, 
(A269nm@1mm-A320nm@1mm) × 6 × 1017/#of base pair of the viral DNA (7234) = # of viral 
particles/ml. The concentration of CoMoCAT was calculated using the equation, 
A990nm@1cm×13= µg/ml. For Hipco, an empirical equation, A632@1cm×27.8=µg/ml, was used. 
For 99% metallic and 99% semiconducting SWNTs, the starting concentration was 10 µg/ml 
(NanoIntegris). For the calculation of the number of SWNT per µg of SWNT, we used 1 µg of 
SWNT = 1.06 × 1012 assuming 0.8 nm in diameter and 500 nm in length. Since different 
SWNT solutions have different mean length, the actual number of SWNTs can be different 
for various SWNTs. The mean lengths of the used SWNTs are similar to or longer than 500 
nm but still shorter than 1 µm, and therefore the calculated number of SWNT could be 
overestimated but no more than by a factor of two. Accordingly, the actual virus-to-SWNT 
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ratio of 1:5 could be less than that but not higher than 1:2.5. Based on our experimental 
results, the device performance of the SWNT-DSSCs was not sensitive in the virus-to-SWNT 
ratios from 1:2.5 to 1:5, and therefore the effect of electronic type of SWNTs on device 
performance is still valid. For the study of the effect of the bundling, the discussion is also 
valid because the same SWNTs were used for the complexation. 
 
Complexation of virus/SWNT 
Calculated amount of SWNT-binding virus solution was mixed with the calculated 
volume of SWNTs dispersed by 2 wt% sodium cholate (SC) in water. The mixed solution was 
dialyzed against water (10 mM NaCl, pH =5.3) for two days with frequent solution changes. 
After two days of dialysis, the pH of the dialyzing solution was increased to 10. A dialysis 
membrane, MWCO of 12,000-14,000 (SpectraLabs) was used for all dialysis procedure.  
 
Zeta potential measurement 
The concentration of virus solution used was 1012/ml in water with 10 mM NaCl. The 
stock solution of virus (~ 1014/ml) was initially dissolved in 10 mM Tris, 15 mM NaCl before 
diluting in 10 mM NaCl in ddH2O.  The solution amount used to generate curve was 30 ml. 
The ionic concentration of the solution was as set to 10 mM NaCl for all samples to minimize 
the fluctuation of ionic strength during pH adjustment. The pH was then adjusted using 0.1 M 
NaOH until the pH was around 10. Zeta potential was then measured at an accumulation time 
of 10 with 5 measurements per sample at 20 V using DelsaNano (Beckman Coulter).  
Electrophoretic mobility was calculated using the Smoluchowski approximation (used for 
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particles larger than 0.2 µm in 1 mM or greater salt solution). pH was then adjusted with 0.1 
M HCl.  
 
Photoluminescence (PL) measurement 
PL from SWNTs was measured with a home-built near-infrared (NIR) PL microscope. 
An inverted microscope was coupled to a Princeton Instruments OMA V 1D InGaAs array 
detector through a PI Acton SP2500 spectrometer. As excitation sources, a 785 nm-laser and a 
Xe lamp coupled to a monochromator were used for PL spectra and PLE mapping, 
respectively.  
 
High-resolution transmission electron microscopy (HRTEM) 
For HRTEM, JEOL 2010F TEM was used. For TEM analysis, virus-SWNT solutions 
were dropped onto Cu Quanti-foil holey grid (TedPella), washed with ddH2O several times, 
and dried.   
 
Genetic engineering for M13-BAP 
Biotin accepting peptide (BAP, or Avi-Tag), GLNDIFEAQKIEWHE, identified 
through phage-display technique, was engineered onto p3 of SWNT-binding virus. 
Oligonucleotides, 5[Phos]’ GTA CCT TTC TAT TCT CAC TCT GGC CTG AAC GAC ATC 
TTC GAG GCT CAG AAA ATC GAA TGG CAC GAG TC 3’ and 5[Phos]’ GGC CGA 
CTC GTG CCA TTC GAT TTT CTG AGC CTC GAA GAT GTC GTT CAG GCC AGA 
GTG AGA ATA GAA AG 3’, were purchased from IDT (idtdna.com) and annealed to form a 
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DNA duplex. The cloning vector was extracted from SWNT binding virus using standard 
miniprep kit (QIAGEN). The extracted vector was digested with Eag I and Acc65 I enzymes 
dephosphorylated, and agarose-gel purified. Purified vector and DNA duplex were ligated 
using T4 DNA ligase at 16oC overnight, and electrotransformed to electrocompetent XL-1 
blue cells. Transformed cells were incubated for 1 h, plated, and incubated at 37°C overnight. 
Blue plaques were amplified and DNA sequenced to confirm the insertion of oligonucleotides 
for BAP on pIII. 
 
Biotinylation of BAP  
Biotin accepting protein (BAP) of DSPH-BAP was biotinylated using BirA enzyme 
(Avidity) according to the manufacturer’s recommendation (Avidity). Briefly, DSPH-BAP 
virus was reacted with BirA enzyme in Biomix-A and Biomix-B solution at 30°C for 12 h. 
After the reaction, the virus was purified by standard PEG/NaCl precipitation method.  
 
Magnetic separation method 
For the magnetic separation method, biotinylated SWNT-binding viruses were 
complexed with SWNTs and incubated with streptavidin-coated magnetic beads. After 
incubation, the magnetic beads were pulled out of the solution, and the remaining solution 
was compared with the initial virus-SWNT solution (Fig. 4.2a). The remaining solution was 
clear whereas nonspecific binding of SWNT onto the streptavidin-coated magnetic beads in a 
control sample was negligible (Fig. 4. 2b), implying the successful binding of SWNT on the 
virus. 
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4.4. Results and discussion 
 
Synthesis of Nanocomposites: Complexation and Biomineralization 
To synthesize SWNT/TiO2 nanocomposites, virus/SWNT complexes are made, and 
then TiO2 nanocrystals are biomineralized on the complexes. Figure 4.1 illustrates the 
synthesis of virus-templated SWNT/TiO2 nanocomposites. To bind and disperse SWNTs non-
covalently along the viruses wrapped by p8 major coat proteins, a p8 library (25) was 
constructed and viruses with binding affinity toward SWNTs were identified through a bio-
panning method. In the p8 library construction, the gene for p8, gVIII, is engineered to 
express foreign peptide inserts, and therefore all 2,700 copies of p8 coat proteins express the 
peptide inserts, enabling cooperative and multivalent interaction between the surface of 
viruses and SWNTs. Among several identified clones, a specific virus with the p8 insert 
sequence of DSPHTELP was selected for SWNT binding for two reasons. First, it has an 
aromatic residue, histidine (H), which is expected to interact with SWNTs through π-π 
stacking (26) at all pH ranges. Second, the pKa of the side chain of histidine is around 6, and 
therefore histidine in the selected sequence allows us to neutralize the virus surface without 
disrupting the virus stability. SC-dispersed SWNTs are initially negatively charged due to the 
cholate ions non-covalently adsorbed on the SWNTs, and viruses are also negatively charged 
at pH of D.I. water, ~6. Therefore, the overall interaction between viruses and SWNTs during 
the surfactant exchange  (27) is determined by competition between binding affinity and 
electrostatic repulsion. To minimize the initial electrostatic repulsion between viruses and 
SWNTs, thus facilitating the binding, the pH of the dialyzing solution was set to the pI of the 
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virus, 5.3. After the complexation was completed, the pH was increased to 10, at which point 
the zeta potential of the virus becomes around -35 mV. This increased negative surface charge 
of the virus is advantageous for both colloidal stability (28) of the complexes and nucleation 
of TiO2 on the complex template. Using histidine as a pH-switch, the repulsion between 
viruses and SWNTs is reduced, while the repulsion between cholate-SWNTs still exists in the 
early stage of the complexation, minimizing possible bundling of SWNTs. Therefore, by 
utilizing the pH-switch, SWNTs are expected to be better dispersed. The virus/SWNT 
complexes made with this pH-switch retained 82% of the integrated photoluminescence (PL) 
intensity (935 nm~1,250 nm) of the starting SWNT solution, increasing by 2.8 times 
compared to those made at constant pH 10. Since metallic SWNTs in the small bundles of 
SWNTs quench PL (18), higher PL intensity implies better dispersion of SWNTs. Therefore, 
the selected virus allows efficient binding and dispersion of SWNTs through pH-dependent 
control. The binding between SWNTs and viruses was confirmed using a magnetic separation 
method (Fig. 4.2). To visualize the bound SWNT along the major coat proteins of the virus, 
high-resolution transmission electron microscopy (HRTEM) was used (Fig. 4.3). Because part 
of the SWNT surface is exposed to water, biomineralized nanocrystals on viruses make a 
direct contact with SWNTs.  
After SWNTs are bound by viruses, biomineralization of TiO2 on the virus/SWNT 
template was optimized to achieve heterogeneous nucleation of TiO2 and maintain the 
structural integrity of the virus/SWNT complexes during the synthesis. To suppress fast 
hydrolysis of titanium alkoxides at room temperature  (29), TiO2 was biomineralized at 
lowered temperature (-20°C) and in 75% ethanol solution (typical SWNT-to-TiO2 weight 
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ratio is 1:100). In Figure 4.4, the wire-like structure in the TEM micrograph confirms the 
templated growth of TiO2 on the virus. Raman spectrum of the photoanode after the device 
fabrication (Fig. 4.5) shows radial breathing mode (RBM) peaks and the G peak from SWNTs 
(31), implying the presence of SWNT/TiO2 complexes. Compared to other methods for 
making TiO2/CNT complexes (14, 15, 19, 31), this virus-enabled self-assembly method has 
several advantages. First, SWNTs are bound and stabilized by viruses through non-covalent 
binding, and therefore no chemical modifications are required, preserving high electron 
mobility of SWNTs. Second, the partially exposed surface of SWNT in the virus/SWNT 
complex enables direct contact between SWNTs and TiO2, facilitating electron transfer at the 
interface. Lastly, an excess of virus is not required to disperse SWNTs. Surfactants need to be 
at a higher concentration than critical micelle concentration, typically ten to a hundred times 
more than the viruses used for stabilizing SWNTs. These free surfactants make heterogeneous 
nucleation of TiO2 on the surface of SWNTs difficult.  
 
Effect of Electronic Type of SWNTs on Photovoltaic Device Performance 
To investigate the effect of SWNTs on electron collection in photovoltaic devices, we 
chose DSSCs as a model application due to their potential as practical devices and their well-
understood device physics (2, 7, 32). For easy comparison, DSSCs with only TiO2 
nanoparticles as photoanodes were fabricated with the same method that other groups 
reported, and used as a control. The SWNT/TiO2 nanocomposites were mixed with TiO2 
nanoparticles (SWNT concentration in TiO2 matrix varies from 0 to 0.2 wt%) and fabricated 
for DSSCs using the same method, except that the devices were annealed in an Ar atmosphere 
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(instead of air) to protect SWNTs and at elevated temperature (600°C instead of 500°C) to 
remove viruses and polymers. Devices with only TiO2 nanoparticles annealed at two different 
conditions showed similar power conversion efficiencies, confirming the different annealing 
conditions used here did not affect the power conversion efficiency. Device structures and 
photoelectrochemical processes in SWNT-incorporated DSSCs are described in Figure 4.6. 
TiO2 nanoparticles accept electrons from photo-excited dyes, and these electrons are 
transferred to the conduction band of SWNTs after diffusion among TiO2 nanoparticles. Then, 
SWNTs transport the electrons quickly to the current collector (fluorine-doped tin oxide, 
FTO) to prevent back-electron transfer and recombination. In Figure 4.7, I-V curves of 
DSSCs with different electronic types of SWNTs incorporated into photoanodes are shown. 
When pure semiconducting SWNTs (99% semiconducting components) are used, the short-
circuit current (ISC) increases by 27%, while pure metallic SWNTs (99% metallic 
components) decreases ISC by 20% compared to TiO2-only DSSCs. All fill factors are 
approximately 0.7, and all open-circuit voltages are around 780 mV. Electron diffusion 
lengths of photoanodes are calculated from electrochemical impedance spectroscopy (32) and 
shown in Figure 4.8. Electron diffusion length increases by incorporating semiconducting 
SWNTs, but decreases when metallic SWNTs are incorporated. These changed electron 
diffusion lengths result in different electron collection efficiencies of the devices, and account 
for the different power conversion efficiencies. Therefore, semiconducting or metallic 
SWNTs affect the device power efficiency differently by increasing or decreasing electron 
diffusion length, thus electron collection efficiency. These opposing effects can be understood 
from the different electronic band structures of semiconducting and metallic SWNTs (Fig. 
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4.9). Semiconducting SWNTs have a non-continuous band structure with a diameter-
dependent bandgap (16). The electrons in the SWNT conduction band, transferred from the 
TiO2 conduction band, can transport quickly to FTO without recombination or back reaction. 
In contrast, metallic SWNTs have a continuous band structure, and therefore electrons 
transferred from TiO2 can stay at continuous energy levels near the Fermi level, accelerating 
recombination of electrons to dye or back reaction to tri-iodide in the electrolyte.  
The importance of the virus/SWNT template for synthesizing compact SWNT/TiO2 
complexes and effectively incorporating them into DSSCs is demonstrated by following 
control experiments (Fig. 4.10) DSSCs with virus/TiO2 complexes but without SWNTs show 
similar performance to the devices with only TiO2 nanoparticles. This indicates that the 
viruses do not participate in the photoelectrochemical processes (The template mass is only 
about 10% of the total TiO2), and one-dimensional morphology of the virus/TiO2 complexes 
does not affect device performance significantly. Instead, viruses bind SWNTs, prevent 
SWNTs from bundling, and act as templates for synthesizing SWNT/TiO2 core-shell 
nanocomposites. Another control experiment using surfactant-stabilized SWNTs shows lower 
device efficiency. Free surfactants in solution favor homogeneous nucleation as opposed to 
heterogeneous nucleation for the encapsulation of SWNTs in TiO2 when using virus-
stabilized SWNTs. Homogeneous nucleation of TiO2 results in SWNTs with exposed surfaces 
(SWNT bundles appear after synthesis), increasing electron recombination and back reaction 
in DSSCs. Additionally, more surfactants than viruses are required to stabilize SWNTs, 
resulting in more impurities. Decreased efficiencies induced by bundling and impurities are 
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also observed in the control experiment where as-produced SWNTs without surfactants were 
used.  
To optimize the electron collection, SWNT concentration dependence of power 
conversion efficiency was studied. Various concentrations from 0 to 0.2 wt% of SWNTs with 
different compositions of semiconducting and metallic components were incorporated into 
photoanodes. DSSCs incorporated with pure semiconducting SWNTs show continuous 
increases of efficiency, followed by saturation (from 8.3% for devices with only TiO2 
nanoparticles to 10.3% for devices with 0.2 wt% SWNTs), as shown in Fig. 4.11. The 
increase of the power efficiency is mainly due to the increased photocurrent. One possible 
explanation for the saturation could be that the concentration of SWNTs in the TiO2 matrix is 
sufficient for electrons to transfer quickly to SWNTs (Approximate calculation shows that 
electrons can transfer to SWNTs after several hops between TiO2 nanoparticles with 0.1 wt% 
SWNTs.). When SWNTs with more metallic components are incorporated, however, the 
concentration dependence of the device efficiencies varies from having an optimized value 
with CoMoCAT SWNTs (about 10% metallic components) to a monotonic decrease with 
Hipco SWNTs (about 33% metallic components) and pure metallic SWNTs (about 99% 
metallic components). Although there have been reports on using other carbon-based 
nanomaterials for photovoltaic devices, for example, multi-walled carbon nanotubes (33), 
mixed semiconducting and metallic SWNTs (14, 15), and graphene (34-36), there has been no 
report explicitly showing the opposing effects of metallic and semiconducting SWNTs on 
photovoltaic device performance. The differences between results in this report and those 
from others could be attributed to the following explanations. First, the efficiencies of our 
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devices with only TiO2 nanoparticles are relatively high (Fig. 4.7), implying that the 
recombination and back reaction are not severe. Therefore, these devices are more sensitive to 
additional metallic components. Second, well-dispersed SWNTs and compact SWNT/TiO2 
nanocomposites allow us to systematically investigate the effect of semiconducting and 
metallic components separately. Third, annealing condition of 600°C and Ar atmosphere 
ensures better contact between SWNTs and TiO2 and prevents SWNT loss in device 
fabrication.  
Since SWNTs also absorb visible light, the possible effect of optical loss from SWNTs 
on device performance was investigated. The spectral response of IPCE for DSSCs with and 
without SWNTs, and SWNTs of different electronic types and concentrations were measured 
(Fig. 4.12). For metallic SWNTs, the maximal absorption wavelength in the visible region is 
around 700 nm, which does not overlap with the absorption peaks of N719 dye (Fig. 4.13). 
Therefore, the optical loss from metallic SWNTs does not affect the spectral shape of IPCE. 
For semiconducting SWNTs, although the maximal absorption wavelength in the visible 
region is around 500 nm, overlapping with the absorption peak of N719 dye, IPCE does not 
show significant change around 500 nm. This indicates that optical loss from semiconducting 
SWNTs is not severe and does not affect the spectral shape of IPCE. Therefore, the different 
device performances we observed do not result from optical loss of SWNTs.  
 
Effect of the Degree of Bundling on Photovoltaic Device Performance 
The observed effects of semiconducting SWNTs and metallic SWNTs on the device 
performance motivated further tuning of the degree of bundling of SWNTs with the virus. To 
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investigate the effect of bundling of SWNTs on device performance, virus/SWNT complexes 
with virus-to-SWNT ratios of 1:2.5, 1:5, and 1:10 were made. Since the PL is more sensitive 
to bundle formation  (18) than the absorption, PL spectra of complexes are used to compare 
degree of bundling of SWNTs. Because all the starting SWNT solutions used for 
complexation are from the same batch and at the same concentration, the change of PL 
intensity is directly related to the degree of bundling of SWNTs. The integrated PL intensity 
(930 nm~1,250 nm) of the 1:10 sample is 5 times smaller than the 1:2.5 sample, whereas the 
1:5 sample is only 1.67 times smaller (Fig. 4. 14). The lowest PL intensity of the 1:10 sample 
implies a more bundled state than the 1:2.5 and 1:5 samples. The severer bundling of SWNTs 
in the 1:10 sample was further confirmed by PL excitation (PLE) map. In the PLE map of the 
1:10 sample, the relative PL intensity of (7,5)-chirality is higher than both (8,3)- and (6,5)-
chiralities, which is the opposite in the PLE maps of the 1:2.5 and 1:5 samples (Fig. 4.15). In 
bundled SWNTs, in addition to the quenching of PL, excitons in ‘donor’ SWNTs with larger 
bandgap, can transfer to ‘acceptor’ SWNTs with smaller bandgap, and radiatively recombine 
to produce photons of lower energy (24, 37). Therefore, the reverse of relative PL intensity of 
(7,5)-SWNTs in 1:10 sample can be explained as exciton energy transfer from donor (8,3)- 
and (6,5)-SWNT to acceptor (7,5)-SWNT. The PLE mapping results show similar tendency of 
degree of bundling to PL spectra.  
Complexes with different virus-to-SWNT ratios were fabricated into DSSCs. The 
devices with the most bundled SWNTs (1:10) have the lowest power conversion efficiency, 
9.1%, while devices with less bundled SWNTs (1:2.5 and 1:5) show higher values, 9.9% and 
10% (Fig. 4.16). Therefore, the degree of bundling of SWNTs also plays an important role in 
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photovoltaic device performance. Moreover, the 1:2.5 ratio gives a two times higher density 
of virus/SWNT complexes in TiO2 matrix than the 1:5 ratio for the same concentration of 
SWNT. Thus, tuning the degree of bundling of SWNTs can reduce the amount of 
incorporated SWNTs further. By optimizing the effect of electronic properties of SWNTs and 
the microstructure of the template, we achieved a non-trivial improvement of power 
efficiency of DSSCs from 8.3% to 10.6% by incorporating only 0.1 wt% SWNTs (Fig. 4.17). 
This 10.6% power conversion efficiency of DSSCs is the best result for any SWNT-
incorporated photovoltaic devices.  
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4.5. Conclusion  
 
We developed a general and programmable method to template compact core-shell 
SWNT/nanocrystals nanocomposites using a genetically engineered virus. Using this method, 
SWNTs are stabilized without surfactants and surface modifications, and their electronic 
properties are preserved. With the developed biological template approach, we demonstrate 
that well-dispersed semiconducting SWNTs can improve the power conversion efficiency of 
DSSCs; even with 0.1 wt% of semiconducting SWNTs incorporated, the power efficiency 
increased by 28% (from 8.3% to 10.6%). We also explicitly show that metallic and 
semiconducting SWNTs affect the device performance in the opposite way, and aggregation 
states of SWNTs affect the device performance, guiding further studies in incorporating 
SWNTs in photovoltaic devices.   
Because SWNTs have good thermal conductivity (38) in addition to high electron 
mobility, this approach might improve the stability of large DSSC modules. Moreover, 
biological engineering of multiple genes (39) of the virus can extend this approach to creation 
of more complex structures. Though the route to DSSC improvement lies in the development 
of dyes with absorption extending into the infrared and better redox couples for higher 
voltages (40), we believe that our approach will enable the utilization of SWNTs in many 
practical photovoltaic devices that require efficient electron diffusion and reduced electron 
recombination, for instance, quantum dot solar cells (41), organic solar cells, and 
photoelectrochemical cells.  
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4.6. Figures  
 
Fig. 4.1. A schematic diagram for the process of virus/SWNT complexation, and 
biomineralization of TiO2 on the surface of virus/SWNT complex.  
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Fig. 4.2. Magnetic separation of M13/SWNT complexes. a, M13-SWNT complexes. 
complexes i, SWNT binding viruses of which pIII are enzymatically biotinylized were 
complexed with SWNTs (left), combined with streptavidin-coated magnetic beads (right), and 
(ii) incubated. iii, Incubated solution is pulled out using magnet placed external to the tube of 
the solution. iv, The supernatant is compared with the starting virus/SWNT solution, 
confirming binding of SWNT to the virus. b, Surfactant dispersed SWNTs. SWNTs are not 
pulled out of the solution. 
a. 
 
b. 
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Fig. 4.3. High-resolution transmission electron microscopy of M13-SWNT complex. M13 
virus is guided by dotted line and SWNT is indicated by an arrow.  
 
 
 
Fig. 4.4. TEM image of TiO2 templated on M13-SWNT complexes 
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Fig. 4. 5. Raman spectrum of the photoanode incorporated with SWNT/TiO2 complex 
after being annealed in Ar at 600°C. In addition to peaks of SWNTs, peaks of anatase TiO2 
are also shown. 
 
 
Fig. 4.6. A scheme of DSSCs incorporated with SWNT/TiO2 complex.  
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Fig. 4.7. I-V curves of three DSSCs incorporated with different electronic types of 
SWNTs, compared with no-SWNT incorporated DSSCs. 
 
Fig. 4.8. Calculated electron diffusion lengths from three DSSCs. L is the film thickness 
and Ln is the electron diffusion length. 
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Fig. 4.9. Energy diagram of DSSCs incorporated with semiconducting SWNTs and 
metallic SWNTs 
a. Semiconducting SWNTs 
 
b. Metallic SWNTs  
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Fig. 4.10. Device performance of control DSSCs. Device performance of DSSCs with only 
TiO2 nanoparticles (black line), TiO2 nanoparticles and virus/TiO2 complex without SWNT 
(red line), TiO2 nanoparticles with surfactant-stabilized SWNT (blue line), and TiO2 
nanoparticles with as-produced SWNT powders (cyan line). 
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Fig. 4.11. Dependence of the power conversion efficiency and short-circuit current of 
DSSCs on the electronic type and the concentration of SWNTs incorporated in TiO2 
matrix. Virus-to-SWNT ratio of 1:5 was used for all devices.  
 
 
 
 
 
 
 
 
 
  102 
Fig. 4.12. IPCE measured for various DSSCs.  
 
 
Fig. 4.13. Comparison of absorption spectra from SWNTs and N719 dye in the visible 
region.  
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Fig. 4. 14. PL spectra of virus-SWNT complex solutions with various virus-to-SWNT 
ratios. The integrated PL intensity (935 nm ~ 1,250 nm) of the 1:1 complex is 82% of the 
starting SWNTs in 2wt% SC aqueous solution. This high quantum yield of the virus-SWNT 
complexes suggests that the developed virus-SWNT complexation method is an efficient way 
of dispersing SWNTs in aqueous solution. CoMoCAT SWNTs were used for the 
complexation. 
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Fig. 4.15. PLE maps of virus/SWNT complexes with virus-to-SWNT ratios of 1:2.5 (a), 1:5 
(b) and 1:10 (c). CoMoCAT SWNTs are used for the complexation. As the ratio of virus-to-
SWNT increases (from a to c), the degree of soft bundling of SWNTs is increased.  
 
d
c
b
a
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Fig. 4.16. The effect of bundling of SWNTs in virus/SWNT complexes on device 
performance. Dependence of power conversion efficiency and short circuit current on the 
degree of bundling of SWNTs, controlled by virus-to-SWNT ratio. CoMoCAT SWNTs are 
used with the concentration of 0.1 wt% in DSSCs. 
 
Fig. 4.17. Device performance of the best DSSC in this study. Current density and Power 
efficiency versus voltage curves of the DSSC with 0.1 wt% SWNTs of 99% semiconducting 
component incorporated ((6,5)-chirality-enriched SWNT). The highest power conversion 
efficiency is 10.6%. The virus-to-SWNT ratio is 1:2.5. 
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Chapter 5. M13 virus-functionalized single-walled 
carbon nanotubes for targeted imaging of tumors 
using second near-infrared window fluorescence 
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5.1. Abstract 
 
Fluorescence in vivo imaging using second near-infrared (NIR) window light (950 – 
1,400 nm) is attractive due to greater penetration of light through tissue from low absorption 
by blood and tissue, low autofluorescence background and short acquisition time. Single-
walled carbon nanotubes (SWNTs) show great promise as fluorescence imaging probes due to 
their NIR fluorescence in the second optical window. If fluorescent SWNTs can be equipped 
with targeting functionality, then the capability of in vivo fluorescence imaging will be greatly 
enhanced for accurate, specific detection of diseased areas such as malignant tumors. 
Although SWNTs have previously been used for fluorescence imaging of live cells in vitro 
and whole animals in vivo, actively targeting in vivo fluorescent imaging has not been 
achieved. Here, a new approach to functionalizing SWNTs for molecularly targeted 
fluorescence imaging of tumors in the second NIR window regime is developed. Using 
genetically modifiable, multifunctional M13 virus, SWNTs have been successfully utilized 
for targeted fluorescence in vivo imaging for the first time. With antibody-targeted M13-
SWNT probe, we can resolve tumors using second NIR window fluorescence imaging. 
Targeted probes show specific and four-fold improved uptake in prostate specific membrane 
antigen (PSMA) positive prostate tumors compared to control non-targeted probes. Moreover, 
the M13-SWNT probe is detectable in deep tissues even at a low dosage of 2 µg/ml and up to 
2.5 cm in tissue-like phantoms. This initial work has great implications for specific detection 
and therapy monitoring of hard-to-detect areas.  
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5.2. Introduction 
 
Single-walled carbon nanotubes (SWNTs) show great promise as in vivo imaging 
agents due to their unique optical properties (1-4). In particular, their photoluminescence (PL) 
in the second near-infrared (NIR) window (950-1,400 nm) and their interband transitions in 
the first NIR window (650 -950 nm) allowing for excitation far from the emission line make 
SWNTs promising imaging agents for in vivo fluorescence imaging due to deeper penetration 
of light through tissue and low autofluorescence (5).  
Due to the extremely hydrophobic surface of SWNTs and the sensitivity of the 
fluorescence to defect creation and bundle formation, it is challenging to achieve stable, 
biocompatible, and bright SWNTs with sufficient intensity for in vivo second NIR window 
fluorescence imaging. It has been recently reported that SWNTs prepared by surfactant 
exchange with biocompatible phospholipid-polyethylene glycol are highly bright and can be 
successfully utilized for whole animal in vivo imaging (4), indicating the fluorescence 
intensity of SWNTs is critical for in vivo fluorescence imaging. Coupling targeting 
functionality to brightly fluorescent SWNTs would greatly enhance second NIR window 
fluorescence imaging for specific, accurate detection of targets such as malignant tumors and 
minimize non-specific uptake (6). However, there has been no report on method to prepare 
targeted SWNTs with bright enough fluorescence for in vivo imaging. To the best of our 
knowledge, SWNTs for actively targeted in vivo second NIR window fluorescence imaging 
has never been demonstrated. 
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Here, we demonstrate genetically modifiable, multifunctional M13 virus as a platform 
to functionalize SWNTs for targeted fluorescence imaging of tumors. M13 virus is a versatile 
scaffold with five capsid proteins that can display material-specific peptides (7, 8) or targeting 
motifs (9) through genetic engineering. In addition, its filamentous shape (length ~880 nm 
and diameter ~6.5 nm) allows for cooperative and multivalent interaction with SWNTs, 
resulting in stable complexes (Fig. 5.1). In this work, M13-SWNT has been investigated as an 
efficient in vivo fluorescence imaging probe and further exploited for targeted fluorescent 
imaging. By independently engineering multiple genes of M13 virus, we successfully 
incorporated targeting moieties into SWNT without significantly compromising the 
fluorescence of SWNTs. 
 
 
 
 
 
 
 
 
 
 
 
 
  113 
5.3. Experimental 
 
Absorption spectroscopy and NIR photoluminescence excitation mapping 
Absorption measurements were taken with a Shimadzu UV-3101 PC UV-VIS-NIR 
Scanning Spectrophotometer. PL from SWNT was measured with a home-built near-infrared 
(NIR) PL microscope. An inverted microscope was coupled to OMA V 1D InGaAs array 
detector (Princeton Instruments) through Acton SP2500 spectrometer (Princeton Instruments). 
For three-dimensional profile, a Xe lamp coupled to a monochromator was used as excitation 
source.  
 
Mouse handling 
All animal handling and procedures were done in accordance with Institutional 
Animal Care and Use Committee protocols. For tumor studies, human xenografts prostate 
tumors were induced in six-to-eight week old male nude nu/nu mice (Charles River 
Laboratories). Mice were subcutaneously injected in the right flank with 3,000,000-4,000,000 
LNCaP cells suspended with equal volume of Matrigel (BD Biosciences). Tumors were 
grown until they reached 3-7 mm in diameter. Mice were dosed with M13-SWNT probes by 
retro-orbital injection. For ex vivo analysis, mice were sacrificed at 24 h p.i. and organs were 
collected, measured and weighed. 
 
NIR fluorescence whole-animal imaging  
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An in vivo imager has been built for this study (Fig. 5.1b). As a detector, a liquid 
nitrogen-cooled OMA V 2D InGaAs array detector (detection range: 800 – 1,700 nm) with a 
256 × 320 pixel array (Princeton Instruments) was used. In front of the detector, NIR camera 
lens (SWIR-25, Navitar) was attached. To minimize autofluorescence from tissues and 
maximize the detection of fluorescence from SWNTs, two stacked long-pass filters with cut-
off wavelength of 1,100 nm and OD >4 (EdmundOptics) were used. For the excitation, an 
optical fiber coupled 808 nm diode laser (MDL-F-808, OptoEngines) was used and a laser 
line filter with center wavelength of 808 nm (EdmundOptics) was attached in front of the 
laser to remove any unwanted excitation light. To minimize the exposure of the laser onto the 
mouse, a computer-controlled shutter was set-up. The actual fluence on the mouse for in vivo 
imaging was ~120 mW/cm2. The acquisition time for in vivo imaging was 0.1 s ~ 1 s. For the 
contrast images, the same detector was used but a white light was illuminated instead of an 
808 nm laser.  
 
NIR fluorescence imaging of M13-SWNTs in phantoms 
To get a stacked 3D image, phantoms were scanned along the depth direction with a 
scanning velocity of 0.5 mm/s, controlled by two-axis traveling stage controller (100 mm 
maximum travel length in each direction, Thorlabs), with a collimated laser of ~5 mm in 
diameter (collimator, F230SMA-B, Thorlabs), and fluorescence images of the phantom were 
collected every 0.5 s. The collected images, after background subtraction, were used to 
construct a 3D stacked image (Fiji, freeware), giving the depth information of the probe. 
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Specific conjugation of PSMA antibody onto the p3 of SWNT-binding M13 virus.  
To conjugate PSMA antibody to the p3 of SWNT-binding M13 virus (DSPH) (10), the 
virus was genetically engineered to express biotin-accepting peptide (BAP) on p3 and then 
enzymatically biotinylated. DSPH-BAP was biotinylated using BirA enzyme (Avidity) 
according to manufacturer’s recommendations (Avidity). Briefly, DSPH-BAP was reacted 
with BirA enzyme in Biomix-A and Biomix-B solution at 30°C for 12 h. After the reaction, 
the biotinylated virus was purified by standard PEG/NaCl precipitation method. To conjugate 
PSMA antibody (abcam) to p3, the antibody was conjugated with streptavidin using Easy 
Link Streptavidin conjugation kit (abcam). Approximately 500 µl of virus-SWNT complex 
solution at 3 × 1013 complexes/ml was incubated with 10 µl of streptavidin-conjugated 
antibody at room temperature for 12 h.  
 
Cell lines and culture 
DU145 human prostate carcinoma cell line was provided courtesy of Dr. Kimberly 
Kelly (University of Virginia). LNCaP human prostate carcinoma cell line was purchased 
from ATCC. DU145 was grown in Dulbecco’s Minimum Essential Medium (DMEM, 
Hyclone) supplemented with 10% fetal bovine serum (FBS) (Hyclone) and 1% 
penicillin/streptomycin (Invitrogen) at 37°C in 5% CO2. LNCaP were grown in phenol red-
free RPMI medium (Hyclone), supplemented with 10% FBS, 1% penicillin/streptomycin, 1% 
sodium pyruvate (Invitrogen), and 1% HEPES buffer (Invitrogen) 37°C in 5% CO2. 
  
In vitro binding assay  
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To compare various binding ligands of M13-SWNTs, a binding assay was done using 
the imager. In a poly-lysine coated, black 96-well plate, 30,000 cells (either LNCaP or 
DU145) were plated in each well and 100 µl of complex solution with a concentration of 
1012/ml (SWNTs concentration: ~ 1µg/ml) was added to each well, incubated at 37°C for 4 h. 
After incubation, wells were washed three times with PBS and PL was measured. PL intensity 
was averaged over three wells. The acquisition time was 1 s for all samples.  
 
Flow cytometry 
To determine SPARC expression, DU145 and LNCaP cells were harvested. 1,000,000 
cells/sample were incubated with complete media and spun at 1,200 rpm for 5 min. After 
centrifugation, samples were washed two times with PBS and fixed with cold 4% 
paraformaldehyde for 10 min at room temperature. After two washes, cells were washed with 
0.2% saponin in PBS (SAP) for 10 min. Cells were centrifuged at 1,200 rpm for 5 min. Cells 
were then incubated with 1: 20 mouse isotype  (abcam) or anti-human SPARC-phycoerthrin 
(PE) (R&D Systems) in SAP buffer. After washes, samples were run on FACScan (Becton 
Dickinson) and gated for 10,000 events. Samples were run in triplicate. For PSMA 
expression, DU145 and LNCaP were harvested and washed once with PBS. After 
centrifugation, samples were incubated with 1:100 mouse isotype-PE (abcam) or mouse anti-
PSMA-PE (abcam). After 30 min, samples were washed twice with PBS and run on 
FACScan. For each experiment, 10,000 events were gated. Samples were run in triplicate.  All 
analysis was done using FlowJo software. 
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NIR fluorescence microscopy 
For NIR fluorscence imaging of sectioned tumor tissues, samples were excited by 658 
nm laser and imaged and monitored using inverted microscope with liquid nitrogen-cooled 
OMA V 2D InGaAs detector and an AxioCam MRm charge-coupled device (CCD) camera.  
 
Immunohistochemistry 
Tissues and tumors were harvested, embedded in OCT resin and snap frozen in dry 
ice. Samples were cut into 5 µm sections. Immunostaining was done using ThermoScientific 
Autostainer 360. For immunostaining, sections were blocked with 3% H2O2 and blocked for 
endogenous mouse IgGs prior to incubation with 1:150 mouse anti-PSMA (Lifespan 
Biosciences) in PBS.  Sections were then incubated with secondary horseradish peroxidase 
conjugate (ThermoScientific) and DAB chromogenic substrate (Ultravision). Samples were 
imaged using Olympus IX51 inverted microscope.  
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5.4. Results and discussion 
 
To assess M13-SWNT as an efficient fluorescence imaging agent, optical properties 
and fluorescence stability were first investigated. In this study, SWNTs prepared by high-
pressure carbon monoxide (HiPCO) were chosen rather than fluorescent semiconductor-rich 
CoMoCAT SWNTs since HiPCO SWNTs have more SWNT species with relatively large 
diameters which fluorescence at longer wavelengths (up to ~1,600 nm) than CoMoCAT 
SWCNTs (up to ~1,100 nm) (10). The absorption spectrum and PL excitaion (PLE) map of 
the M13-SWNT probe in phosphate-buffered saline (PBS) are compared to SWNTs dispersed 
by 2wt% sodium cholate (SC) in distilled water, denoted as SC-SWNTs (Fig. 5.2). The 
optical transition peaks of M13-SWNTs show a small red shifting, most obvious in the 
lowest-energy interband transition (wavelengths > 900 nm).  The red shifting is due to 
different dielectric environments surrounding the SWNTs after surfactant exchange with the 
M13 virus (11), and small bundling of SWNTs during the complexation (10). The relative 
quantum yield of M13-SWNT probe, calculated by comparing integrated PL intensity (957 
nm- 1,291 nm), is about 40% of the starting SC-SWNTs, and this relative quantum yield of 
M13-SWNTs is high enough for in vivo imaging as shown later (Figs. 5.4 and 5.10). To test 
fluorescence stability, the M13-SWNT probe in PBS was mixed either with cell culture media 
supplemented with 10% fetal bovine serum (FBS) or FBS, and NIR PL intensities of solutions 
were measured at various time points up to 24 h after mixing (Fig. 5.3). M13-SWNTs in PBS 
and the culture media with 10% FBS retained most of their integrated PL intensity throughout 
the tested period, while the probe in FBS showed a slight decrease in the PL intensity after 3 h 
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incubation. The decrease of PL intensity could be attributed to the adsorption of serum 
proteins on the sidewall of SWNTs (12) because the surface of SWNTs bound by M13 is 
partially exposed to the solution (10). However, the PL intensity remained around 90% after 
the initial decrease and did not show noticeable aggregation, indicating the probe is very 
stable (13). These serum stable, brightly fluorescent M13-SWNT probes show promise for in 
vivo imaging.  
 We next examined the potential of the M13-SWNT probe for in vivo fluorescence 
imaging using a custom-built NIR imager (Fig. 5.1b). Mice were imaged from the dorsal side 
before and after intravenous injection  (Fig. 5.4). Before injection, there is negligible tissue 
autofluorescence, which is one of the advantages of second NIR window fluorescence 
imaging. At 10 min post-injection (p.i.), fluorescent M13-SWNTs are visualized throughout 
the vasculature and are evident in the highly fenestrated, vascular-rich kidneys. This 
vasculature is still visible but less obvious at 1 h p.i. and becomes featureless at 4 h p.i., 
consistent with the blood circulation behavior (Fig. 5.5). Moreover, fluorescence from M13-
SWNT probe is mostly observed in liver, spleen, and bone due to immune clearance by these 
organs of the reticuloendothelial system. Similar clearance has been reported with other 
nanomaterials (14) including SWNTs (15) and quantum dot (>20 nm) probes (16). The clear 
raw signal from liver and spleen is detected from the dorsal side, which is challenging to 
obtain using visible or first NIR window light. We could detect M13-SWNT probes in deep 
organs even at a low dosage of 2 µg/ml of SWNTs (0.022 mg/kg) (Fig. 5.6) and up to 2.5 cm 
depth in tissue-like phantoms (Fig. 5.7), highlighting the advantages of the second NIR 
window fluorescent M13-SWNT probe.  
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Taking advantage of the versatility of the M13 scaffold, various targeting moieties 
were then incorporated into M13 and screened for targeting in vitro. To couple targeting 
functionality to SWNTs without compromising the fluorescence of SWNTs, minor coat 
protein p3, located at the proximal tip of M13 and spatially separated from SWNT-binding p8 
proteins, are engineered to express either peptide ligands or peptide handles for site-specific 
antibody conjugation (Fig. 5.1a). A peptide identified from phage display against Secreted 
Protein, Acidic and Rich in Cysteine (SPARC) (SPARC-binding peptide, designated as SBP) 
(17) was genetically engineered into the p3 protein of the SWNT binding M13. SPARC is a 
matricellular protein overexpressed in various cancers, including prostate, breast and skin 
(reviewed in reference (18)). For an antibody binding system, we engineered a 15-amino acid 
biotin acceptor peptide (BAP) tag (19) onto the p3 of M13 for site-specific conjugation of 
antibodies. The enzymatically biotinylated peptide allows us to add any streptavidin-
conjugated antibodies for desired targeting and removes the need for more complex and non-
specific conjugation chemistries. Here we conjugated an antibody against the extracellular 
domain of prostate specific membrane antigen (PSMA). PSMA has been previously identified 
as a cell surface marker overexpressed in various prostate carcinomas and endothelial cells of 
tumor vasculature (20, 21). M13-SWNT probes displaying SBP, PSMA antibody, or no 
ligand  (denoted as SBP-M13-SWNT, anti-PSMA-M13-SWNT, and M13-SWNT, 
respectively) were incubated on LNCaP (higher SPARC expression and PSMA positive) and 
DU145 (low SPARC expression and PSMA negative) human prostate cancer cell lines and 
NIR fluorescence was measured to quantify specific uptake. There is about 5.3-fold and 8.3-
fold enhanced uptake of SBP-M13-SWNT and anti-PSMA-M13-SWNT in LNCaP compared 
  121 
to DU145, respectively (Fig. 5.8). In the control, there is only minimal background 
fluorescence present in DU145 and LNCaP and no targeting was observed. These results 
correlate with the expression level of PSMA and SPARC (Fig. 5.9). Flow cytometry confirms 
PSMA expression in LNCaP, whereas DU145 is negative for PSMA (Fig. 5.9, top row). 
Moreover, there is moderate SPARC expression in LNCaP compared to DU145 control (Fig. 
5.9, bottom row). Interestingly, there is approximately 3.9-fold improvement in LNCaP 
targeting using anti-PSMA-M13-SWNT compared to SBP-M13-SWNT (Fig. 5.8). This could 
be explained by the difference in the number of cell surface markers, as confirmed by flow 
analysis. However, it is also possible that the different binding affinity of peptide versus 
antibodies may affect uptake (22).  By testing target and control cell lines, this in vitro assay 
allows us to screen and validate uptake and specificity of our probes. 
Based on in vitro screening, we identified anti-PSMA-M13-SWNT as our best 
candidate probe for subsequent investigation of tumor targeting and imaging in vivo. Upon 
formation of LNCaP tumors, mice were injected intravenously with 200 µl of 30 µg/ml anti-
PSMA-M13-SWNT and control M13-SWNT and imaged at several intervals up to 24 h p.i.. 
The fluorescence signal from anti-PSMA-M13-SWNT targeted tumor is clearly observed 
after 2 h p.i. and reaches maximum 200% increase in PL intensity at 4 h p.i. (Figs. 5.10, right 
column and 5.11). At 4 h p.i., mice injected with anti-PSMA-M13-SWNT show four-fold 
improved tumor uptake compared to control M13-SWNT. At this timepoint, the probe has 
already cleared circulation and has accumulated in tumors. Tumors injected with negative 
control M13-SWNT probe have an initial increase upon intravenous injection, but decrease 
and reach background levels, suggesting minimal accumulation (Figs. 5.10, left column and 
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5.11). Interestingly, at 1 h p.i., both tumored mice show similar levels of PL increase (Figs. 
5.10 and 5. 11) due to circulating probes (Fig. 5.5), making it difficult to specifically discern 
tumors. After 4 h, there is a decrease of anti-PSMA-M13-SWNT accumulation in tumors, and 
this behavior may be mediated by M13 virus. Similar kinetics of targeted virus accumulation 
in tumors has been reported by others (17). Probes targeting molecules overexpressed in 
tumor vasculature can exit, leading to decreased tumor accumulation at later time points. 
Since M13 is a large macromolecule (> 200 nm) and less likely to penetrate the vascular wall 
compared to small drugs or peptides (22), it targets PSMA also overexpressed in the tumor 
vasculature (21). 
To further confirm targeting, probe uptake in tumors was analyzed ex vivo. To 
quantify tumor uptake relative to muscle background, fluorescent images of the excised tumor 
and muscle were acquired and fluorescent intensities of image regions of interest were 
obtained. The NIR PL ratio of tumor to muscle of anti-PSMA-M13-SWNT is ~2.9 and this 
ratio is about two fold higher than non-targeted M13-SWNT (~1.4) (Fig. 5.12a), indicating 
preferential tumor uptake of anti-PSMA-M13-SWNT. NIR fluorescence microscopy of 
sectioned tumors also confirms anti-PSMA-M13-SWNT accumulation (Fig. 5.12b, upper 
right panel), whereas M13-SWNT is not seen in tumors (Fig. 5.12b, upper left panel). 
Immunohistochemical staining of adjacent tumor sections (Fig. 5.12b, bottom row) shows 
PSMA expression in both tumors, confirming uptake of anti-PSMA-M13-SWNT is specific 
and not artifactual.  
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5.4. Conclusion 
 
Using M13 virus-functionalized SWNTs as imaging probes, we have achieved for the 
first time molecularly targeted second NIR window fluorescence imaging of tumors. By 
genetically engineering the multiple capsid proteins of M13 virus independently, we 
successfully incorporated targeting capability into SWNTs without compromising the in vivo 
stability of the fluorescence of SWNTs. M13-SWNT probe was detectable in deep tissues 
even at a low dosage (2 µg/mL) and up to 2.5 cm in tissue-like phantoms, showing the 
potential of the probe for early, non-invasive diagnosis and clinical procedures, such as intra-
operative surgery (13, 23, 24). Future work to develop image processing methods (25) and 
enhance signal amplification of M13-SWNT through utilizing longer SWNTs (26), additional 
genetic engineering of the M13 virus for multiple peptide display (27), and synthesizing 
hybrid materials for metal enhanced fluorescence of SWNTs (28), will allow us to image 
traditionally hard-to-detect areas. 
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5.5. Figures 
 
Fig. 5.1. Schematic of the imaging probe and home built NIR whole animal fluorescence 
imager. (A) M13-SWNT imaging probe: p8 is used to stably disperse SWNTs. p3 is 
engineered for targeting. (B) NIR fluorescence imager developed for this study. a: 808 nm 
diode laser, b: liquid-nitrogen cooled two-dimensional InGaAs detector, c: 808 nm laser line 
filter, d: 1,100 nm long-pass filter, e: lens for NIR light, f: collimator, and g: stage controller 
for x- and z- directional travel of the laser.  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Fig. 5.2. Optical properties of M13-SWNT probe. (A) UV-vis-NIR absorption spectra and 
(B) PL excitation (PLE) map of M13-SWNTs in PBS compared to SWNTs dispersed by 
2wt% sodium cholate (SC) in distilled water (denoted as SC-SWNTs). There is small red 
shifting of peaks. HiPCO SWNTs are used for all studies.   
  
 
 
 
 
 
 
 
 
 
  126 
Fig. 5.3. Fluorescence stability. M13-SWNT is incubated in phosphate buffered saline 
(PBS), tissue culture media with 10% fetal bovine serum (FBS) and FBS, and PL intensity is 
measured up to 24 h.   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Fig. 5.4. Fluorescence images of M13-SWNT injected mouse at various time points. At 
10 min and 1 h post-injection, vasculature and fenestrated kidneys can be observed. Dosage 
was 0.33 µg of SWNT/g (200 µl of 30 µg/ml SWNTs probe solution) and acquisition times 
for all images were 0.5 s.  
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Fig. 5.5. Blood circulation behaviour of the M13-SWNT probe. SWNT concentration was 
calculated from calibration (bottom) The circulation life was determined as the timepoint 
when %ID/g of SWNT in blood falls to 5, and the blood circulation of M13-SWNT was 
approximately 60 min. Each data point is the mean ± s.d. from n=3 animals. 
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Fig. 5.6. Dosage limit of the M13-SWNT probe for mouse imaging. Fluorescence image of 
a mouse injected with 2 µg/ml (200 µl, 0.022 mg/kg of SWNTs) probe solution. Liver and 
spleen are clearly seen on the dorsal side. Image was taken at 2 h p.i. Acquisition time was 0.5 
s.  
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Fig. 5.7. Penetration depth of M13-SWNT in tissue-like phantom studies. Quartz capillary 
tube of M13-SWNT (left) is inserted into 6 cm3 tissue phantom (middle) and imaged using 
custom-built imager. Reconstructed 3D stacked image (right) shows M13-SWNT detectable 
at 2.5 cm depth.   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Fig. 5.8. Targeting of the probe in vitro. In vitro binding assay of SBP, anti-PSMA, and no 
ligand displayed on the probe and incubated on LNCaP and DU145 prostate carcinoma cell 
lines. PL intensities are measured using custom-built imager. Acquisition times were 1 s for 
all samples.  
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Fig. 5.9. Expression of PSMA and SPARC in LNCaP and DU145 cell lines. FACS 
analysis shows expression of PSMA and SPARC in LNCaP (A, C blue histogram), 
respectively. Expression is not seen in DU145 cell line (B, D blue histogram). Red histogram 
is control.  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Fig. 5. 10. In vivo targeting of tumors. In vivo second NIR window fluorescence images for 
LNCaP tumor-bearing mouse injected with anti-PSMA-M13-SWNT (right column) or M13-
SWNT (without ligand, left column) probes, taken at different time points. The clear tumor 
uptake of anti-PSMA-M13-SWNT injected mouse, maximized at 4 h p.i., shows active 
targeting capability of the probe. Tumor areas are indicated by white arrows. Acquisition 
times for the M13-SWNT mouse and the anti-PSMA-M13-SWNT mouse were 0.3 s and 0.5 
s, respectively. 
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Fig. 5.11. Kinetics of tumor targeting. Each data point is the mean ± s.d. from n=3 animals. 
*P <0.01 for the entire set of data compared to no-ligand, using student t-test for paired data 
with one-tailed distribution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  136 
Fig. 5. 12. Ex vivo analysis of tumor targeting. (A) Relative targeted tumor uptake of anti-
PSMA-M13-SWNT compared to no ligand control was determined from NIR PL intensity 
ratios of tumor to muscle. Tumors and muscles were collected at 24 h p.i.. Acquisition times 
for all samples were 0.5 s. Each data point is the mean ± s.d. from n=3 animals. *P <0.05 
compared to no-ligand, using student t-test for paired data with one-tailed distribution. (B) 
Probe uptake in vivo and immunohistochemistry (IHC) (lower row). LNCaP tumors were 
injected with anti-PSMA-M13-SWNT or M13-SWNT (without ligand) probe, shown in the 
right column and left column respectively. Five micron-cut serial sections were measured for 
SWNT fluorescence (upper row) and stained for PSMA expression (brown) (bottom row). 
PSMA expression in both tumors confirms anti-PSMA-M13-SWNT uptake (upper right 
panel) is specific and non-artifactual. The acquisition times for PL microscopy were 1 s and 
images for IHC were taken at 15 ms.   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Chapter 6. Multifunctional virus-based platform 
for efficient theranostic agents 
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6.1. Abstract  
 
This work presents an M13 virus-based platform for targeted, simultaneous NIR 
fluorescence imaging and therapy through spatial control of targeting ligands, SWNTs and 
drug. The multifunctional virus stably disperses SWNTs and delivers drugs to targeted human 
prostate cancer cells. Targeted virus-SWNT complex demonstrates selective and sensitive 
fluorescence imaging of prostate cancer cells. Drugs delivered by the targeted virus complex 
inhibited cell growth of targeted cancer cells at least 245 times more efficiently than free 
drug. This multifunctional virus-based approach provides a platform for theranostics and is 
potentially powerful due to the interchangeability of its components, permitting study of a 
wide array of cancers. 
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6.2. Introduction 
 
The unique optical, electronic and magnetic properties of nanomaterials have 
positioned them at the center of nanobiotechnology with applications in the diagnosis and 
therapy of a myriad of diseases.  For example, semiconducting quantum dots with tunable 
emission spectra (1) and Au nanorods with strong surface enhanced light scattering and 
absorption (2) have been used as imaging agents and coupled with cytotoxic species to form 
therapeutic agents. Nanomaterials as combined therapy and diagnostic agents, or theranostics, 
can be used to monitor and treat tumors and track drug efficacy accurately. Although many 
studies have demonstrated successful imaging or drug delivery using nanomaterials, few 
strategies have been reported to provide a platform for simultaneous therapy and diagnostics. 
Single walled carbon nanotubes (SWNTs) are an attractive material as an imaging agent in 
vivo because their band-gap fluorescence in the second window near infrared (NIR) 
wavelength range (950 nm -1,400 nm) enables deep tumor imaging with low tissue scattering 
and autofluorescence background.  
As with most nanomaterials for biomedical applications, it is necessary to stabilize 
SWNTs with biocompatible and functionalized coatings to reduce toxicity and improve 
pharmacokinetics. Moreover, for fluorescence imaging, SWNTs need to be non-covalently 
functionalized to retain their unique fluorescence (3). Small molecules such as DNAs (4), 
small peptides (5) and various phospholipid-polyethylene glycols (PL-PEG) (6) have been 
utilized to solubilize SWNTs in aqueous solutions. Previous work has reported SWNTs 
stabilized by small coating molecules functionalized with targeting ligands or drugs for cancer 
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imaging or therapy (reviewed in (3)). However, with non-covalent functionalization, it is 
challenging to effectively couple drugs and targeting ligands on these small molecule coatings 
simultaneously while maintaining the colloidal stability of SWNTs. Colloidal stability of non-
covalently functionalized SWNTs is important for fluorescence imaging because unstable 
SWNTs eventually form bundles and lose fluorescence due to quenching by metallic tubes 
present in the initial SWNT composition (1). To the best of our knowledge, however, no 
single materials platform has demonstrated stable, targeted, simultaneous second window NIR 
fluorescence imaging and drug delivery.  
To address these concerns, we propose using M13 virus, as a multifunctional platform 
that stably disperses SWNTs non-covalently and that allows for targeted imaging and delivery 
(Fig. 6.1). M13 virus has five genetically modifiable proteins (proteins p3, p6, p7, p8, and p9) 
that can display material-specific peptides or targeting motifs on various coat proteins (7-9). 
Multifunctionality can be engineered into M13 virus for applications in nanoelectronics, high 
power Li ion batteries, and photocatalytic water splitting (7, 10-13). In addition, the 
filamentous shape of M13 virus (~6.5 nm in diameter and ~880 nm in length) and the highly 
ordered structure of the 2,700 copies of the major coat protein p8 enable the virus to 
multivalently and cooperatively interact with one-dimensional nanomaterials such as SWNTs. 
Further, drugs can be chemically conjugated onto available functional groups of p8 by 
controlling virus to SWNT ratio. Minor coat protein p3, located at the proximal tip of M13 
and spatially segregated from SWNT-binding p8 proteins, can be genetically engineered to 
target biomarkers overexpressed on cancer cells. While most SWNT-based biomedical 
applications conjugate targeting molecules or drugs directly onto SWNTs, here we utilize a 
  144 
genetically engineered virus as a unique platform to spatially control targeting, imaging and 
therapeutic moieties for theranostics.  
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6.3. Experimental 
 
Cell lines and culture 
DU145 and C4-2B human prostate cancer cell lines were provided courtesy of Dr. 
Kimberly Kelly (University of Virginia). LNCaP human prostate cancer line was given as a 
gift by Dr. Juliana Chan (Massachusetts Institute of Technology). DU145 was grown in 
Dulbecco’s Minimum Essential Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS) (Hyclone) and 1% pencillin/streptomycin (Invitrogen) at 37°C in 5% CO2. C4-
2B were grown in T-medium (Invitrogen) with 10% FBS and pencillin/streptomycin. LNCaP 
were grown in RPMI medium (without phenol red), supplemented with 10% FBS, 1% 
penicillin/streptomycin, 1% sodium pyruvate, and 1% HEPES buffer. 
 
NIR PL Imaging in vitro 
500,000 DU145, LNCaP, and C4-2B cells were plated on poly-lysine coated 35 mm 
glass bottom plates (MatTek Corporation). Cells were incubated with 2 ml of 0.29 µg/mL 
M13-SWNT in Dulbecco’s phosphate buffer saline (DPBS) with calcium and magnesium 
(Hyclone) for 12 h at 37°C. Cells then were washed three times and resuspended with DPBS. 
For PL imaging of targeted cells, nanotubes in the cells were excited by 658 nm laser and 
imaged and monitored using inverted microscope with OMA V 2D InGaAs array detector 
(Princeton Instruments) and an AxioCam MRm charge-coupled device (CCD) camera. 
Spectra were collected for 5 -20 s at 658 nm. 
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Targeting in vitro using PL spectrometry 
1,000,000 DU145, LNCaP and C42B cells were plated on 6-well plates (BD 
Biosciences) and incubated with 2 ml of 1.8 µg/mL M13-SWNT solution. Samples were 
washed three times with DPBS and harvested with trypsin (Hyclone). Cells were spun down 
and resuspended in 100 µL DPBS. Samples were placed in a 96-well glass bottom plate 
(MatTek) and PL intensity was measured in the wavelength of 1,000 – 1,350 nm. Samples 
were excited for 5 min. Spectra were subtracted against background. Cells were counted using 
a ViCell analyzer (Beckman Coulter) and used to normalize PL intensity measurements. 
Samples were measured in triplicate. 
 
DOX conjugation onto M13-SWNT-SBP 
Doxorubicin (DOX) hydrochloride was purchased from Sigma-Aldrich and EDC and 
Sulfo-NHS were purchased from Thermo Scientific. The conjugation was proceeded 
according to the product protocol. The complex (M13-SWNT-SBP) concentration was 
1013/ml and that of DOX was 50~100 µg/ml for the conjugation reaction.  After conjugation, 
the reaction was quenched and dialyzed against PBS for 2 days using dialysis membrane, 
MWCO of 12,000 ~ 14,000, (SpetraLabs) with frequent buffer exchange.   
 
Cytotoxicity Assay 
To evaluate cytotoxicity, M13-SWNT-SBP-DOX and M13-SWNT-SBP were 
incubated with C4-2B and DU145 cells for 9 h at 37° C in 50% DPBS.  Complexes were 
removed and cells were washed with PBS and were subsequently grown for 14 h in complete 
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DMEM or TMEM.  An MTT assay was used to quantify cell growth.  Briefly, cells were 
incubated with 12 mM MTT reagent for 4 h.  Cells were then washed and incubated with 
SDS-HCL for another 4 h.  The reaction was mixed, and the absorbance was read at 570 nm. 
Samples were measured in quadruple.  
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6.4. Results and discussion 
 
To bind and disperse SWNTs in biocompatible solutions for fluorescence imaging 
agent, SWNT-binding virus, named as p8cs#3, DVYESALP, identified through bio-panning 
method with p8 library was utilized. Since the hydrophobic moiety of the p8 protein of 
p8cs#3 is small and approximately only 155 of 2,700 copies of p8 are bound by SWNT in the 
1:1-M13-SWNT complex, the vast majority of the surface of the complex remains 
hydrophilic. In addition, the native negative surface charge of M13 contributes to the colloidal 
stability of M13-SWNT through electrostatic repulsion.  The zeta potential of the complex is 
~45 mV at pH 7.4 (Fig. 6.2); colloidal particles with absolute zeta potential above 15 mV are 
considered stable (14).  These combined effects allow M13 to stabilize SWNTs in PBS, 
culture media, and serum and prevent SWNT bundling (Fig. 6.3), obviating the need for 
chemical functionalization. 
After confirming stability and non-cytotoxicity of the complexes, we examined the 
ability of M13-SWNT to target and image metastatic prostate cancer cells by incorporating a 
targeting motif into p3 (Fig. 6.1).  Expression profiling has identified secreted protein, acidic 
and rich in cysteine (SPARC) as a biomarker upregulated in various human cancers (15, 16). 
SPARC, an anti-adhesive and promigratory matricellular glycoprotein, is overexpressed in 
patients with aggressive melanoma, breast, brain, prostate, colon, and lung cancers (reviewed 
in (17)). SPARC may facilitate cancer cell invasion and dissemination and is correlated with 
poor prognosis, suggesting that it may be an excellent biomarker for identifying and staging 
metastatic lesions (17).  We investigated SPARC-specific targeting in metastatic prostate 
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cancer cells using M13-SWNT as a NIR fluorescent probe. A binding peptide identified 
against SPARC (SPPTGIN, designated as SBP) (18) was genetically engineered into the p3 
minor coat protein of M13 (p8cs#3) (Fig. 6.1). The targeted complex, M13-SBP-SWNT, was 
incubated with human prostate cancer cell lines LNCaP, C4-2B (SPARC positive; C4-2B is 
LNCaP derived line which metastasizes to the bone) and DU145 (SPARC negative) at 
physiological conditions and imaged in the NIR second window (950-1,400 nm) using a two-
dimensional InGaAs detector. C4-2B and LNCaP showed noticeable fluorescence (Fig. 6.4a, 
bottom right, and middle), whereas DU145 control did not exhibit any fluorescence (Fig. 6.4a, 
bottom left). Punctate fluorescence was observed in the cytosol, suggesting possible vesicular 
uptake (Fig. 6.4a). To quantify targeting, cells were incubated with M13-SBP-SWNT and 
harvested for spectra measurements. The fluorescence intensity was integrated from 1,120 nm 
to 1,350 nm and normalized (Figs. 6.4b, c). C4-2B and LNCaP exhibited eleven and five-fold 
greater intensities than the DU145 control, respectively (Fig. 6.4c). Even after considerable 
incubation, there is negligible non-specific binding to control DU145 (Figs. 6.4a-c). The 
imaging and spectra suggest M13-SBP-SWNT can actively and discriminately target cells in 
vitro at relevant physiological conditions. This selective and sensitive fluorescence probe 
illustrates the potential of our virus-based approach for targeting and imaging in vivo 
metastases in the NIR regime.  
To investigate the potential of the virus-based platform for theranostics, M13-SBP-
SWNT complex was further conjugated with chemotherapeutic agents. Doxorubicin (DOX) is 
an athracycline antibiotic and a common chemotherapeutic agent that acts by inhibiting 
topoisomerase II activity to produce stable DNA double strand breaks (19). While it has been 
  150 
extensively used in the clinic to treat ovarian, breast, lung, uterine and cervical cancers, DOX 
injury to non-target tissues via induction of oxidative stress often results in limited DOX 
dosing regimens (20). As such, efficient and targeted delivery of DOX to neoplastic lesions 
would lower non-specific toxicity and increase the clinical utility of DOX.  
To actively deliver DOX to targeted cancer cells with fluorescent SWNTs, DOX was 
conjugated onto virus by forming a peptide bond between the free amine group on the drug 
and carboxylic acids (aspartic acid (D) and glutamic acid (E)) on the major p8 major coat 
proteins of M13 (p8cs#3)-SBP using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
and Sulfo-NHS (Fig.6.1) after virus-SWNT complexation.  The red color of DOX was used to 
visually confirm loading on M13-SBP-SWNT (Fig.6.5). DOX loading was quantified by 
measuring optical absorption of the complex at 490 nm: extinction coefficient of DOX at 490 
nm is 23 cm2/mg (Fig. 6.6a) (21). The number of loaded drugs on the M13-SBP-SWNT 
complex decreased as the overall ratio of SWNT to virus increased eliminating the possibility 
of non-covalent loading of drug on the SWNT surface. An average of 390-450 DOX 
molecules were loaded per virus when one SWNT is bound per virus, and DOX loading did 
not interfere with SPARC mediated targeting or SWNT fluorescence (Fig. 6.6b).  The final 
complex is very stable in PBS and the cytotoxicity of drugs was not degraded even after 
several weeks from complexation. This stable multifunctional virus construct allows for 
simultaneous targeted NIR imaging and cytotoxic drug delivery to tumor cells.  
 
In order to investigate the drug delivery efficacy by M13-SBP-SWNT-DOX complex, 
C4-2B and DU145 human prostate cancer cell lines were incubated with M13-SBP-SWNT-
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DOX and cell viability was analyzed using an MTT assay.  M13-SBP-SWNT-DOX 
drastically inhibited growth of SPARC-expressing C4-2B cells while it had a less significant 
effect on SPARC negative DU145 cells (Fig. 6.6c), demonstrating targeted chemotherapy.  In 
contrast, free DOX inhibited cell growth of both cell lines (Fig. 6.7d). Moreover, M13-
SWNT-SBP-DOX was more than 245 times more efficient at inhibiting cell growth than free 
DOX (Fig. 6.6d). For C4-2B, the half maximal inhibitory concentration, IC50, of free DOX 
was 29.5 µg/ml while that of M13-SBP-SWNT-DOX was 0.12 µg/ml. For DU145, the IC50 
for free DOX was 198 µg/ml while that of M13-SBP-SWNT-DOX was 28.9 µg/ml (Fig. 
6.6e). Further, M13-SBP-SWNT did not significantly retard cell growth (Fig. 6.7) under the 
same condition used for the MTT assay for M13-SBP-SWNT-DOX, highlighting DOX as the 
mechanism of cell death. The mechanism of DOX release from virus could be due to protease 
present in the cells. The amino-terminus of the genetically engineered p8 protein may be 
cleaved by intracellular proteases (Fig. 6.1).  For example, chymotrypsin, a serine protease 
abundant in mammalian cells, is known to selectively cleave the carboxyl-terminus of 
aromatic residues and may cleave the tyrosine (Y) residue in the p8cs#3 sequence (Fig. 6.1).  
Therefore DOX bound to the aspartic acid residue (D) can be released and maintains its 
cytotoxic functionality (22).  
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6.5. Conclusion 
 
The M13-SBP-SWNT-DOX platform allows for simultaneous active targeting, second 
NIR window fluorescence imaging, and chemotherapy in vitro. The M13 scaffold stably 
disperses SWNTs without losing their optical properties. The engineered virus encodes for 
cell-targeting functionality and is a carrier for drug conjugation and delivery, obviating the 
need to conjugate functional moieties directly to SWNTs and potentially compromise their 
stability and fluorescence.  The virus-based platform circumvents these potential issues and 
allows for spatial control of targeting ligands and drugs with SWNTs. This versatile 
technology is powerful due to the interchangeability of its components, permitting study of a 
wide array of cancers. Potentially, any identified targeting ligands can be readily exchanged 
onto p3 for molecular recognition of various cancers. Additional chemotherapeutic agents 
could be added or substituted by chemical conjugation or molecular recognition for specific 
targeted therapy of many diseases. The selective and sensitive imaging of cancer cells and 
efficient drug delivery enabled by the probe shows a potential of this platform for facile 
imaging and detection of metastases and simultaneous monitoring of the efficacy of drug 
therapy regimens.  
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6.6. Figures 
 
Fig. 6.1. A schematic showing engineered proteins of the M13 virus and materials used 
in this study (a) M13-SBP-SWNT-DOX complex. A minor coat protein, p3, located at the 
proximal tip of the virus, allows for peptide display for targeting specific cancer cells while 
major coat protein, p8, are binding a single-walled carbon nanotube and delivering 
chemotherapeutic agent, doxorubicin, to the targeting specific cancer cells. The secondary 
structure of a single p8 protein is shown. Eight-mer peptide sequences were fused to the 
amino terminus of the p8 protein, depicted by a circle. “D” for drug conjugation and “Y” for 
SWNTs binding and drug release. (b) Cross-sectional view of an M13 virus. Helically 
wrapped 2,700 copies of p8 coat proteins allow for multivalent and cooperative binding of 
SWNTs. (Software: Swiss-PDB, structure model: 2C0W.pdb) 
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Fig. 6.2. Zeta potential of the p8cs#3-SWNT complex measured as a function of pH. pI of 
the complex is around 4.5 and zeta potential is about -45 mV at pH 7.4. This strong negative 
zeta potential of the complex contributes to the colloidal stability of the complex through 
electrostatic repulsion between complexes. 
 
Fig. 6.3. Stability of SWNTs in various solutions. Virus-SWNT complexes are stable for 
several months in PBS and for several days in culture media and serum.   
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Fig. 6.4. Second NIR window fluorescence imaging in vitro and analysis. (a) NIR 
fluorescence images and bright field images of M13-SBP-SWNT targeting three prostate 
cancer cell lines with various expression levels of SPARC, C4-2B, LNCaP (positive SPARC) 
and DU145 (negative SPARC). (b) PL spectra from targeting various cancer cells, normalized 
with number of cells. More than 10, 000 cells for each cell are collected for PL measurement. 
(c) Integrated PL intensity from different cell lines.  PL spectra were integrated from 1,120 
nm to 1,350 nm and normalized by the number of cells counted after the PL measurement. P 
values for LNCaP and C4-2B compared with DU145 are also shown. * p<0.0001, ** 
p=0.014. p<0.05 is  statistically significant. 
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Fig. 6.5. Conjugation of DOX onto the M13-SBP-SWNT complex. M13-SBP-SWNT 
complexes conjugated with DOX was precipitated using standard PEG/NaCl precipitation 
method of virus to confirm DOX loading onto the complex. (a) M13-SBP-SWNT with low 
DOX loading and (b) high loading. The black color of (a) is due to SWNT and (b) is due to 
both SWNT and DOX. (c) Free DOX solution (concentration: 0.1 mg/ml) is orange color and 
show strong absorption at 490 nm wavelength.   
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Fig. 6.6. Drug (doxorubicin, DOX) conjugation and cytotoxicity data. (a) UV absorption 
data for virus-SWNT and DOX conjugated virus-SWNT. DOX has an absorption peak at 490 
nm and the concentration was calculated based on its extinction coefficient. An average 
number of conjugated DOX per virus is about 390 ~ 450. (b) PL spectrum from M13-SBP-
SWNT-DOX with and without drug conjugation. Drug conjugation does not quench SWNT 
fluorescence, which allows for simultaneous NIR fluorescence imaging and drug-delivery. (c) 
Cytotoxic data of M13-SBP-SWNT-DOX for C4-2B and DU145. M13-SBP-SWNT-DOX 
drastically inhibits growth of SPARC-expressing C4-2B cells while it has a less significant 
effect on SPARC negative DU145 cells. (d) Cytotoxic data of M13-SBP-SWNT-DOX and 
free DOX for C4-2B. M13-SBP-SWNT-DOX is more than 400x more efficient at inhibiting 
cell growth than free DOX (IC50 of M13-SBP-SWNT-DOX is 0.302 µg/ml while that of free 
DOX is 127.8 µg/ml). (e) IC50 values for M13-SBP-SWNT-DOX and free DOX for C4-2B 
and DU145.  
  159 
 
 
 
 
 
 
 
 
 
 
  160 
Fig. 6.7. Cytotoxicity assays. (a) Dose response of M13-SBP-SWNT-DOX and free DOX for 
SPARC negative cell, DU145. M13-SBP-SWNT-DOX does not inhibit the growth of SPARC 
negative cells. (b) Dose response of M13-SBP-SWNT for C4-2B (SPARC positive) and 
DU145 (SPARC negative). In both cell lines, M13-SBP-SWNT does not inhibit the cell 
growth under the conditions used in this study, highlighting the main cytotoxic effects of 
M13-SBP-SWNT-DOX are due to DOX.  
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Chapter 7. On going works 
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7.1. Graphene/inorganic nanocomposite materials for high power lithium ion batteries: 
in collaboration with Ms. Dahyun Oh and Mr. Xiangnan Dang.  
 
Conversion reaction materials have great potentials due to their larger theoretical 
capacity than the conventional intercalation materials (e.g. LiCoO2 140 mAh/g; 0.5Li+), 
because each chemical formula of the conversion materials reacts with multiple lithium ions 
(MaXb + (b·n)Li ⇔ aM + bLinX). Among conversion reaction materials such as sulfides, 
oxides, nitrides and phosphides (1), fluoride materials (2) provide high reduction potentials 
(above 2 V vs. Li/Li+, which is applicable to cathodes) due to the highly ionic bonds between 
fluorine and metals. However, the practical capacity of conversion reaction materials is 
limited because of low conductivity, and the reversibility of electrochemical reactions is poor 
due to high activation energy. 
Nanocomposites of active materials and conducting materials (e.g. carbon (3), MoS2 
(4), CNT (5), graphene (6)) can be utilized to improve the electronic conductivity of the 
cathode of lithium ion battery. As a conducting additive for nanocomposites, graphene attracts 
great attentions due to its excellent conductivity, large surface area and flexibility. Graphene 
has been incorporated into lithium ion battery electrodes with various materials (LiFePO4 (7), 
SnO2 (8)) by mechanical stirring (ultrasonication) (7) or chemical reduction (9) followed by 
heat treatment. Building an efficient conductive network with graphene would help to 
improve the electrochemical performance of the conversion reaction materials that suffer from 
low electronic conductivity.   
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In this work, genetically engineered M13 virus is be utilized to fabricate 
nanocomposites of graphene/bismuth oxyfluoride for cathodes of lithium ion batteries. First, 
to promote the binding of graphene with M13 virus through π-π and hydrophobic interactions, 
an M13 clone (p8cs#3), identified through bio-panning against SWNTs is chosen. p8cs#3 
clone has aromatic and hydrophobic residues in its major coat proteins (p8), which is expected 
to interact with the graphene surface. In addition, the p3 minor coat protein was also 
engineered to increase the binding affinity between the virus and graphene through 
hydrophobic interaction (10). Secondly, the p8 of p8cs#3 has been further site-mutated to 
express additional carboxyl groups (lysine to glutamate and asparagine to glutamate) to 
improve the nucleation of bismuth oxyfluoride under weakly acidic condition. The final, 
genetically engineered clone is designated as FC#2. 
With this approach, graphene network was successfully incorporated into battery 
electrodes. By using only a small amount (3 wt% of electrode) of graphene, the specific 
capacity of bismuth oxyfluoride has been increased from 120 mAh/g to 210 mAh/g. The 
electrochemical activities of bismuth oxyfluoride at the higher current have also been 
improved, giving 442 W/kg power density. 
 
Construction of FC#2  
To induce more negative surface charge of p8cs#3 virus, 13th amino acid, lysine (K), 
and 17th amino acid, asparagine (N), of the p8cs#3 virus were changed to negatively changed 
amino acid, glutamate (E), using a site-directed mutagenesis (Fig. 7.1.1). The 13th and 17th 
amino acids of p8cs#3 correspond to 8th and 12th amino acid of wild-type virus, and these 
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amino acids are known to be exposed at surface and accessible to ligands (11). This site-
mutated virus is called EFE. Using QuikChange Lightning site-directed mutagenesis kit 
(Stratagene), K was first mutated to E, and N was changed to D and then to E, producing EFE 
virus. The primer sequences used to change K to E are 5' CAG GGA GTT AAA GGC CGC 
TTC TGC GGG ATC CGG CAG CGC 3' and 5' GCG CTG CCG GAT CCC GCA GAA 
GCG GCC TTT AAC TCC CTG 3'; for N to D, primers of 5' GTC GCTGA GGCTT 
GCAGG GAGTC AAAGG CCGCT TTTGC GGG 3' and 5' CCC GCAAA AGCGG CCTTT 
GACTC CCTGC AAGCC TCAGC GAC 3' were used; for D to E, primers, 5' GC TGA GGC 
TTG CAG GGA CTC AAA GGC CGC TTC TGC 3' and 5' GCA GAA GCG GCC TTT 
GAG TCC CTG CAA GCC TCA GC 3' were used. After site-mutation, DNA of EFE was 
sequenced in MIT biopolymers lab.  
To further introduce SWNT-binding functionality to the minor p3 coat protein, 
previously reported SWNT-binding peptide, MC#2 (10) was fused to p3 of EFE virus, 
producing FC#2 virus. To construct FC#2, oligonucleotides, 5 [Phos]’ GTA CCT TTC TAT 
TCT CAC TCT GAT ATG CCG CGT ACT ACT ATG TCT CCG CCG CCG CGT GGT 
GGA GGT TC 3' and 5 [Phos] ' GGC CGA ACC TCC ACC ACG CGG CGG CGG AGA 
CAT AGT AGT ACG CGG CAT ATC AGA GTG AGA ATA GAA AG -3’ (idtdna) were 
annealed to form a DNA duplex. The cloning vector was extracted from EFE virus using 
standard miniprep kit (QIAGEN). The extracted vector was digested with Eag I and Acc65 I 
enzymes, dephosphorylated, and agarose-gel purified. Purified vector and DNA duplex were 
ligated using T4 DNA ligase at 16oC overnight, and electrotransformed to electrocompetent 
XL-1 blue cells. Transformed cells were incubated for 1 h, plated, and incubated at 37°C 
  168 
overnight. Blue plaques were amplified and DNA sequenced to confirm the insertion of 
oligonucleotides for MC#2 on p3.  
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7.1.2. Figures  
 
Fig. 7.1.1. Strategy for dual-functional p8 coat proteins of M13 virus. The green colored 
residues are known to be exposed to the solution (11). K and N of p8cs#3 are site-mutated to 
E, producing EFE virus clone.  
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Fig. 7.1.2. Characterizations of virus mediated bismuth oxyfluoride-graphene 
nanocomposites with TEM and SEM. (A) TEM picture of sulfonated graphene only with 
Selected Area Electron Diffraction (SAED) pattern. (B) TEM image of bismuth oxyfluoride-
graphene nanocomposites with virus. Bismuth oxyfluoride nanowires grown on the graphene 
is observed with lowering particle density. Scale bar inside the small box is 400 nm. (C) SEM 
image of bismuth oxyfluoride-graphene nanocomposites. In the middle of particle aggregation 
(red arrow), graphene sheets can be seen with low contrast. (D) TEM image of bismuth 
oxyfluoride covering graphene with actual synthetic condition for electrodes.  
 
 
 
 
  171 
7.1.3. References  
 
1. Cabana, J. et al., Advanced Materials 2010, 22, (35), E170-E192. 
2. Amatucci, G. G.; Pereira, N. Journal of Fluorine Chemistry 2007, 128, (4), 243-262. 
3. Yamada, H. et al., Journal of Physical Chemistry C 2007, 111, (23), 8397-8402. 
4. Wu, W. et al., Materials Letters 2009, 63, (21), 1788-1790. 
5. Kim, S. W. et al., Advanced Materials 2010, 22, (46), 5260-5264. 
6. Wang, H. L. et al., Journal of the American Chemical Society 2010, 132, (40), 13978-
13980. 
7. Zhou, X. F. et al., Journal of Materials Chemistry 2011, 21, (10), 3353-3358. 
8. Du, Z. F. et al., Materials Letters 2010, 64, (19), 2076-2079. 
9. Li, Y. M. et al., Journal of Physical Chemistry C 2010, 114, (49), 21770-21774. 
10. Lee, Y. J. et al., Science 2009, 324, (5930), 1051-1055. 
11. S. Kneissel, et al., J. Mol. Biol. 288, 21 (1999) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  172 
7.2.1. Efficient electron collection in nanoparticle-solar cells through extended electron 
networks enabled by tri-functional M13 virus: in collaboration with Mr. Xiangnan 
Dang. 
 
In previous work (1), it has been shown that well dispersed, semiconducting SWNTs 
incorporated into phtotoanodes of dye-sensitized solar cells (DSSCs) using M13 virus can 
improve power conversion efficiency of the photovoltaic device through improved electron 
collection. This approach could be more advantageous when applied to other nanoparticle-
based solar cells such as quantum dots solar cells (2) where the electron collection efficiency 
is relatively low compared to TiO2-based DSSCs with electron collection efficiency reaching 
almost maximum. Moreover, the electron collection efficiency of some photovoltaic devices 
could be further improved if photoanodes are formed in a 3D network structure of 
SWNT/nanoparticles core-shell structures.  
An extended network structure of core-shell nanowires can be constructed if p3 and p9 coat 
proteins located at each tip of M13 virus can be utilized, as depicted in Figure 7.2.1. In order 
to realize 3D network structures, three gene-modified M13 virus was developed with p3 and 
p9 coat proteins for site-specific biotinyltion and p8 for SWNT-binding. This three gene-
modified M13 virus (BAP-DSPH-BAP) are used to form a complex with SWNTs, and then 
incubated with streptavidin coated quantum dots (e.g, CdSe) or oxide nanoparticles (TiO2 or 
SiO2) acting as a network point to form an SWNT/nanoparticle nanowire network structure.  
 
Construction of BAP-DSPH-BAP virus clone. 
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To construct BAP-DSPH-BAP virus, an M13 viral vector with gene-modified for p9 
cloning was obtained from Dr. Rana Ghosh. The modified virus has restriction site, BsrG I, 
for p9 cloning for desired peptide inserts. However, because the length of inserts for p9 
cloning is long (552 bp) and the yield of insert-DNA after agarose-gel purification was very 
low, a circular plasmid (pJ201) containing the designed sequence, instead of linear short 
oligonulceotides, was ordered (DNA2.0) and used for the p9 cloning. The designed DNA 
sequence (580 bp) is, 5’-GCC AGC CTA TGC GCC TGG TCT GTA CAC CGT TCA TCT 
GTC CTC TTT CAA AGT TGG TCA GTT CGG TTC CCT TAT GAT TGA CCG TCT 
GCG CCT CGT TCC GGC TAA GTA ACA TGG AGC AGG TCG CGG ATT TCG ACA 
CAA TTT ATC AGG CGA TGA TAC AAA TCT CCG TTG TAC TTT GTT TCG CGC 
TTG GTA TAA TCG CAG GCG GCC AGA GGT GAG ACG TGC TGA CGG CCA GCT 
GAT AAA CCG ATT ACT GTT CGC TGG GGG TCA AAG AAT GAA ATC CCT ATT 
GCC TAC GGC AGC CGC TGG ATT GTT ATT ACT CGC GGC CCA GCC GGC CAT 
GGC GGG CCT GAA CGA CAT CTT CGA GGC TCA GAA AAT CGA ATG GCA CGA 
AGG CCA GGG CGG CCA GGG TGT CGA CAT GAG TGT TTT AGT GTA TTC TTT 
CGC TAG CTT CGT TTT AGG TTG GTG CCT TCG TAG TGG CAT TAC GTA TTT 
TAC CCG TTT AAT GGA AAC TTC CTC ATG AAA AAG TCT TTA GTC CTC AAA 
GCC TCT GTA GCC GTT GCT ACC CTC GTT CCG ATG CTG TCT TTC GCT GCA 
GAT TTC AAG GAT CCC G-3’. For the p9 cloning, restriction sites for BsrG I and BamH I 
were used, located around both ends of the insert sequence (Fig. 7.2.2). After genetic 
engineering of p9, genes for p8 and p3 coat proteins of the p9 modified M13 virus were 
successively engineered to express DSPHTELP and BAP peptides, respectively.   
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Characterization of networking of BAP-DSPH-BAP  
To make it convenient to characterize the network structures of BAP-DSPH-BAP 
virus with transmission electron microscopy (TEM), streptavidin-coated Au (Stv-Au) 
nanoparticels were used instead of other quantum dots or oxide nanoparticles.  In Fig. 7.2.3, 
TEM images of BAP-DSPH-BAP incubated with Stv-Au are shown. There are several joint 
points of virus-SWNTs mediated by Au particles (indicated by red arrows), but not all the 
viruses have multiple contacts and this might be due to non-optimized incubation conditions. 
Au particle bound through the tip of the BAP-DSPH-BAP is clearly shown in Fig. 7.2.3B. 
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7.2.2. Figures 
 
Fig. 7.2.1. Scheme for the 3D network structure enabled by three gene-modified M13 
virus. (A) M13 virus-SWNTs without networking. (B) 3D network of nanowires enabled by 
streptavidin coated nanoparticles and biotinylated p3 and p9 proteins of M13 virus.  
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Fig. 7.2.2. Plasmid map used for p9 cloning. The red segment has inserts for p9 cloning. 
BsrG I and BamH I were used for the p9 cloning.  
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Fig. 7.2.3. TEM images of biotinylated BAP-DSPH-BAP-SWNT incubated with Stv-Au. 
(A) Some of the virus-SWNT complexes are jointed by Au particles (dark, spherical objects), 
some of which are indicated by red arrows. Note that not all the viruses have multiple contacts 
due to non-optimized condition. (B) Individual virus-SWNT with one Au particle bound at 
one end of the virus, either p3 or p9.  
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